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1Abstract 
Aims: The aims of this thesis are to estimate the epidemiology of iNPH in a Norwegian 
population compared to the incidence of surgery for the condition, to assess whether lumbar 
measurements of cerebrospinal fluid pressure (CSFP) concurs with intracranial pressure 
(ICP), and with the clinical response to shunting, and finally to assess which of the lumbar 
hydrodynamic measurements that best can predict the clinical response to shunting. 
Methods: The thesis consists of six publications. Publication I assesses the prevalence of 
iNPH in a Norwegian population. Publication II assesses the five year incidence of surgery 
for iNPH in Norway. Publication III compares lumbar CSFP waves versus ICP waves in 
iNPH. Publication IV compares ICP measured simultaneously within the brain parenchyma 
and cerebral ventricles. Publication V assesses the role of lumbar infusion testing for 
referral of iNPH patients to neurosurgery. Publication VI assesses whether CSFP wave
amplitude during lumbar infusion in iNPH can predict response to shunting.
Results: We found a prevalence of probable iNPH of 21.9/100.000 inhabitants, and an 
incidence of 5.5/100.000/year. The total rate of surgery for iNPH was 1.09/100.000/year. 
The lumbar CSFP wave amplitude during lumbar infusion could be used to predict the ICP 
wave amplitude during over-night monitoring of the intracranial pressure. There is no 
pressure gradient between pressure wave amplitudes derived from brain parenchyma and 
ventricular CSF. Resistance to outflow (Rout) and CSFP wave amplitude derived from 
lumbar infusion related only weakly, while shunt response related highly to the quantitative 
distribution of CSFP wave amplitudes during infusion, giving false negative results in 16% 
of the patients. Elevated CSFP wave amplitudes during lumbar infusion predicted shunt 
response with a sensitivity of 88 and a specificity of 60.
Conclusions: Our data suggest that too few patients are being offered surgical treatment for 
iNPH in Norway. Lumbar CSFP wave amplitudes concur to a great extent with ICP wave 
amplitudes and with clinical response to shunting. Lumbar CSFP wave amplitudes predict 
clinical response to shunting better than Rout, but further studies are advocated to address the 
problem of false negative results from lumbar hydrodynamic measurements. 
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1. Introduction
1.1. Hydrocephalus - Historical overview 
The concept of the cerebral ventricles as the domicile of the human intellect is probably the 
longest surviving theory of brain function, proposed by Herophilos (325 – 255 BC), and 
Erasistratos (304 – 250 BC) working in Alexandria in the 3rd century BC, and not definitely 
rejected until the end of the 18th century, thus surviving 20 centuries (1). According to the 
early theories, stemming from Alexandrian medicine and further elaborated by Galen (130 –
201 AD), the ventricles were not fluid-filled, but contained the “spiritus” or “pneuma”; a 
light gaseous substance considered the agent of the activities now attributed to the neurons 
of the brain parenchyma. The roots of this belief were to a great extent attributable to 
Aristotle (384 – 322 BC), who, in contrast to his predecessors Pythagoras (570 – 500 BC) 
and Hippocrate (approx. 460 – 370 BC), mistakenly attributed voluntary movement and 
intellectual abilities to the heart (2). The existence of the cerebrospinal fluid (CSF) was 
acknowledged by Andreas Vesalius (1514-1564) (3), but not universally recognized until 
Francois Magendie’s (1783-1855) works in the early 19th century (4). In fact, even medical 
authoritative writers as late as Moritz Heinrich Romberg (1795-1873) thought that the 
ventricles were filled with “humid gas” (ibid).
Aulus Cornelius Celsus (approx 25 BC-25 AD) was the first to coin the term 
“hydrocephalus” in his work “On medicine”: “There is a class (of headaches) which may 
become chronic, in which a humour inflates the scalp, so that it swells up and yields to the 
pressure of the fingers. The Greeks call it hydrocephalus” (5), probably meaning 
accumulation of fluid on the outside of the scull. However, it was not before 1768 that 
hydrocephalus was described as a distinctive clinical entity by Robert Whytt (1714-1766) 
(6).  
Although Walter E. Dandy (1886-1946) described third ventriculostomy as early as in 1922 
(7), an effective treatment for the condition was not developed until the 1930’s, when the 
Norwegian neurosurgeon Arne Torkildsen (1899-1968) constructed his method of shunting 
CSF from the ventricular system to the cisterna magna (8). During the 1950’s, the toolmaker 
John W. Holter (1916-2003), together with Eugene Spitz (1919-2006) at the Childrens 
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hospital in Philadelphia, developed the first working shunt valve for the treatment of 
hydrocephalus (9). 
Assessment and monitoring of intracranial pressure (ICP) was introduced by Ernst Victor 
von Leyden (1832-1910) in 1866, performing fluid manometry in dogs (10). In 1878, 
Heinrich Quincke (1842-1922) introduced the spinal puncture technique (11). This 
technique quickly gained widely use in both diagnostics and therapy, even in Norway, as 
exemplified by to extensive reports in two Norwegian medical journals as early as in 1895 
and 1897 (12; 13). 
Measurement of ICP was introduced by Pierre Janny (1921-1993) in the 1950’s (14),
although Nils Lundberg’s (1908-2002) later work was fundamental for the development of 
clinical useful ICP monitoring (15).  
The coining of the term NPH can be dated to 1965, when Hakim, Adams and coworkers 
described a clinical triad of gait disturbance, mental deterioration and urinary incontinence 
coexisting with ventricular enlargement and a normal cerebrospinal fluid pressure on lumbar 
puncture (16; 17). However, several earlier papers described patients with progressive 
symptomatic hydrocephalus without overt signs of intracranial hypertension (18-25), in one 
instant even with relief of symptoms after shunting (25). 
Some the first clinical series showed great surgical success (26; 27), but these were not 
confirmed by subsequent prospective studies (28-30), something which led to a decline in 
the rate of shunt insertions (31). 
1.2. Clinical presentation 
1.2.1. Motor symptoms 
Gait disturbance is often the first clinical sign, and is also the most likely to improve after 
shunting (32-40). No ”classical” NPH gait pattern is considered to exist, although several 
authors describe patients typically having a wide-based ataxic gait with frequent falls at an 
early stage, and at a later stage a small-stepped Parkinson gait with reduced foot floor 
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clearance and start hesitation (35;36;41;42). With progressing disease, turning often 
becomes difficult and requires several steps. This is often referred to as “en bloc”-turning 
(42). Detailed kinematic gait analyses have on the one hand confirmed the presence of 
specific gait abnormalities in NPH-patients, but have on the other hand shown that the gait 
in many aspects resembles the non-specific senile gait disorder with varying both pyramidal, 
extrapyramidal and cerebellar signs (34;43-46). Postural disturbances has also been 
described in NPH-patients, having a more forward leaning stance than healthy normal 
individuals, with a wider sway and an imbalance accentuated by eye closure (47;48). 
Hypokinesia, tremor and hypokinetic or hyperkinetic movement patterns have all been 
described in NPH-patients (49). The pattern of movement in iNPH-patients might resemble 
a parkinsonian pattern. In one study, parkinsonism, as defined by using the motor sections 
of the Unified Parkinson Disease Rating Scale (UPDRS), is reported as a symptom in 71%
of iNPH-patients (50).  
1.2.2. Urinary symptoms 
Increased urinary urgency, and in later stages urinary incontinence, is a feature in NPH. 
Although the exact nature is not well characterized, there is evidence supporting the notion 
that these clinical features are directly caused by detrusor hyperactivity (51). Thus, in a 
recent study by Sakakibara et al, 95% of 41 patients with iNPH had urodynamic evidence of 
detrusor hyperactivity (ibid). Even though urodynamic studies show evidence of detrusor 
hyperactivity in most patients, urinary incontinence per se is therefore not always present, as 
shown in many clinical studies (42;52-54) The so called incontinence sans gêne might be 
present in later stages of the disease, probably due to frontal lobe dysfunction (35), while 
fecal incontinence might occur only in very late stages (42). Some authors argue that the 
incontinence also might not be a specific symptom in NPH, due to a considerable co-
morbidity in the elderly, and that the late stage incontinence might be a secondary feature of 
gait disturbance and more global frontal indifference (55). 
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1.2.3. Cognitive symptoms 
The most evident cognitive symptoms of iNPH, such as slowing of thought, inattentiveness, 
apathy and encoding and recall problems, point to a subcortical dementing process (54). 
Still, very many aspects of cognitive/mental functions might be affected in NPH, ranging 
from impaired wakefulness (56) to reduced attention and concentration (57), reduced 
psychomotor speed (58), reduced memory and learning (ibid) and reduced problem-solving, 
abstract reasoning and executive functions (59-62). In a study by Hellström et al,
neuropsychological deficits were found over a broad range in 58 iNPH-patients as compared 
to healthy controls (63). This study confirmed earlier described associations between the 
severity of cognitive impairment and gait disturbances (64). The fact that the cognitive 
deficits are evident in multiple cognitive domains, and can be detected by a broad range of 
neuropsychological tests, is also reflected by an earlier study, showing that about 60% of 
iNPH-patients score less than 25 on the MMSE (65). Furthermore, it is not possible to 
differentiate between iNPH and Alzheimer’s disease on the basis of subscores on the 
MMSE (64), nor has there been shown a specific neuropsychological profile that can 
reliably differentiate iNPH from other causes of cognitive decline (66).
1.2.4. Is NPH a clinical diagnosis? 
As shown in sections 1.2.1 through 1.2.3, the different symptoms are not distinctive of NPH 
alone. Thus, NPH has no cardinal signs that can clinically distinguish the condition from 
other afflictions of the elderly. It has been proposed that the only reliable means of 
validating the diagnosis of iNPH is to demonstrate a favorable response to shunt treatment 
(26). However, this might result in a high incidence of both false negatives and false 
positives, as elaborated on in section 5.1.1. It is therefore clear that information from other 
modalities, as shown in section 1.6, is important in the diagnostic work-up.  
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1.3. Classification 
Traditionally, NPH is divided in two distinct subgroups, depending on the presumed cause 
in the individual patient. This was evident already from the three NPH-cases described by 
Hakim and Adams in 1965 (17), where two cases were post-traumatic, and one was 
idiopathic. NPH without any known cause is still classified as idiopathic NPH (iNPH), 
while NPH preceded by a presumed causative pathological event is called secondary NPH
(sNPH). The most important known causative events are head trauma, intracerebral or 
subarachnoidal hemorrhage, infection or brain tumor (36;37;67). The exact distribution of 
patients between the two diagnostic groups is not fully known. In a multicenter study from 
Amsterdam constituting a total of 152 patients, 127 (84%) was classified as having iNPH, 
and 25 (16%) was classified as having sNPH (68). In a later Dutch multicenter study 
constituting a total of 101 patients, 89% were classified as having iNPH, and 12% was 
classified a having sNPH (43). Nevertheless, some authors claim that the distribution 
between iNPH and sNPH is approximately 50/50 (39;53;69;70). 
Several of the clinical studies in the field do not make a clear distinction between iNPH and 
sNPH when including, diagnosing, treating or evaluating the patients (31;43;66;71-74). As 
for iNPH, guidelines for the diagnosis and management have been proposed (75), excluding 
patients with sNPH. The authors of the guidelines state that this subdivision was made to 
help simplify the diagnostic approach because the potential for recovery in sNPH patients 
would be more influenced by co-morbidity, but that they learned, in the process of making 
the guidelines, that co-morbidity was equally important in an iNPH population (ibid). Thus,
even though a distinct classification according to the presumed cause can be made (i.e. 
idiopathic or secondary), this distinction is not so evident in many clinical materials, and 
can also be debated in practical classification.  
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1.4. Pathophysiology 
The etiology of iNPH is unknown. The pathophysiology of iNPH also remains to a great 
degree unknown. A number of theories have been launched, but there is presently no 
unifying theory regarding the pathophysiology of iNPH. In the original report, the main 
pathological principle was explained by the so called Hydraulic press hypothesis (17). 
According to this hypothesis, since the total force exerted on the ventricular wall represents 
a product of pressure times surface area, a given pressure will exert a greater force in a large 
ventricular system than in a small one, producing symptoms at a lower pressure level in 
large ventricles than in small ventricles (17). The later theory by Hakim (76) proposed the 
model of the brain as a sponge, where large transmural pressure differences between the 
subarachnoid space and the ventricles cause ventricular enlargement by squeezing water out 
of the brain parenchyma. These hypotheses, however, cannot explain many aspects of the 
condition, such as the finding that the size of the ventricles is inversely correlated to ICP in 
hydrocephalic patients (77), that no transmantle pressure gradient can be found in non-acute 
hydrocephalus (78), that persisting post-poperative ventriculomegaly does not exclude 
significant clinical improvement (79) and that the opening pressure of the cerebrospinal 
fluid does not correlate with the clinical severity in NPH-patients (80). More recent theories 
incorporate a more complex understanding of the intracranial pressure conditions, taking 
into account the dynamic nature of the ICP. A unified and omnipotent theory for the 
pathophysiology of NPH has anyhow yet to be proposed, and must be able to explain both 
the ventricular enlargement and the development of the clinical symptoms, as well as the 
clinical improvement after shunting. Theories have ranged from the abovementioned pure 
mechanical compression of the brain resulted by the dilated ventricles (76), inability to clear 
toxic metabolic products from the CSF as a result of decreased CSF turnover (81;81-83), 
congenital or early acquired hydrocephalus becoming symptomatic in late adult life (84-86), 
and increasing arterial pulse amplitude causing large ICP pulsations and leading to 
secondary parenchymal intracranial damage, the so called “water hammer” theory (87-90). 
The pathophysiological basis of the motor symptoms in NPH is not completely understood. 
The enlargement of the cerebral ventricles has been proposed to lead to affection of the 
upper motor neuron fibers passing through the medial part of the corona radiata (42). This
affection might be partly mechanical, by stretching of the fibers, but also ischemic changes 
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leading to axonal injury might play an essential role (91). Disturbances in basal ganglia 
pathways may have a role in both the gait and cognitive symptoms, as shown in a recent 
position emission tomography study (92), possibly especially affecting the pathways from 
the substantia nigra and basal ganglia to the frontal lobes (93). Frank compression of 
brainstem structures such as the pedunculopontine nucleus might also contribute, as shown a
study where the degree of increase in midbrain volume following shunting correlated with 
clinical improvement (94).
The basis and neuroanatomical localization of the pathophysiological processes leading to 
the urinary symptoms are even less understood. As previously cited, urodynamic studies 
show evidence of detrusor hyperactivity (51), and the indifference towards the incontinence 
in late stages may indicate frontal executive dysfunction (35).  
The cognitive symptoms in NPH are diverse, as previously shown, but point towards a
subcortical dementing process (54). The neuroanatomical basis for this is unclear, but some 
authors argue that a dysfunction in the frontostriatal system is probable (42).
It is becoming increasingly evident that NPH shares common pathological features with 
other degenerative diseases of the CNS. It has been shown that there is a high occurrence of 
Alzheimer-like changes in the cortex of NPH-patients (95-98). It has hence been speculated 
whether Alzheimer’s disease and NPH might have a common pathophysiological basis (81), 
and later studies have shown that the protein pattern in the CSF of NPH patients is similar to 
the protein pattern in Alzheimer’s disease (99). Nevertheless, CSF-shunting in Alzheimer’s 
disease has so far shown no benefit (100). NPH also has a strong relation to cerebrovascular 
disease (101;102), and it has been postulated that subcortical arteriosclerotic 
encephalopathy, or vascular dementia, might be pathophysiologically related to both NPH 
and Alzheimer’s disease (88;103;104). It has also been shown that NPH might present as a 
shunt-responsive type of parkinsonism (50). All these features points to a complex 
interaction between CSF dynamics, cerebral blood flow, brain metabolism and senescent 
physiological changes. 
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1.5. Epidemiology 
Little is known about the epidemiology of NPH. Table 1 in Paper I summarizes the 
epidemiological studies until the year 2007, citing studies that have reported a prevalence 
ranging from 5.38 % of the total dementia population to 0.41 % of all individuals >65 years 
of age, and an incidence ranging from 2.2/million/year to 18/million/year. Two more recent 
population based studies from Japan found, respectively, a prevalence of 2.9 % in the age 
group >75 years (105), and a prevalence of 1.4 % in the age group >65 years (106). The 
variations in the estimates for prevalence and incidence in all the cited studies probably 
reflects very varying diagnostic criteria, ranging from a lack of definition of NPH (71) to
strict classification according to response to shunt treatment (68). The problems of clear-cut 
classification, as discussed in sections 4.2.4 and 4.3, adds to the difficulties of reliably 
assessing the epidemiology of the condition. For further discussion on this point, see section
5.1.1.
Considering the frequency of surgery for iNPH, there are likewise scarce data. In a study by 
Tisell, Høglund et al, the total incidence of surgery for adult hydrocephalus in Sweden 
varied from 2.3 to 3.6/100 000/year between regions during a three year period (107). Even 
though the Swedish study was not designed to study the incidence of operations for iNPH 
alone, iNPH was listed as cause for operation in 243 out of a total of 891 operations, making 
it possible to calculate an incidence of surgery for iNPH of 0.91/100 000/year. 
1.6. Methods of assessment 
The lack of cardinal signs that can clinically distinguish the condition from other afflictions 
of the elderly, together with the incomplete comprehension of the patophysiology, points to 
the need for information from supplemental tests. These are discussed in the following 
sections. 
19
1.6.1. Radiology 
Already early studies showed that assessing structural changes on CT-scans is of little 
prognostic value concerning the clinical response to shunting in NPH (108). Later studies 
have confirmed this (109;110), one also showing that the degree of clinical improvement 
after shunting does not correlate with the decrease in ventricular size (111). Magnetic 
resonance imaging (MRI) permits more detailed morphological evaluation of the 
intracranial compartment. MRI-studies have shown that the diameter of the corpus callosum 
decreases in many cases of iNPH (112). The callosal angle may be increased in iNPH, and 
perihippocampal morphological features may help in distinguishing ventriculomegaly 
secondary to cerebral atrophy from the ventriculomegaly in NPH. Nevertheless, no study 
has shown added diagnostic value of these supportive findings (42). The aqueductal CSF 
flow velocity have been shown to be higher in NPH patients (113), but studies have not 
been able to show a significant correlation between the flow velocity and response to 
shunting (114;115). 
1.6.2. CSF tap test 
In the original report by Hakim and Adams (17), 15 ml of CSF was removed by a spinal tap 
from each of the three patients, leading to a marked clinical improvement. A general 
problem is the lack of universally applicable criteria for improvement after performance of a 
tap test. Nevertheless, this easy test is still widely used for the diagnosis of NPH, although 
the removal of larger volumes, i.e. 40-50 ml is now generally advocated (116). Several 
studies concerning the prognostic value of this diagnostic tool have been conducted 
(65;117-120), and a summary of the referred studies concluded that the positive predictive 
value of this test is good, while the negative predictive value probably is poorer, suggesting 
that many patients who would benefit from shunting would be missed using a negative tap 
test as an exclusion criterion (116).
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1.6.3. External lumbar drainage (ELD) 
The ELD consists, in line with the original report (117) of inserting a lumbar catheter and 
draining 10 ml of CSF per hour for 72 hours. No studies have assessed whether this is the 
most efficient volume and duration. In several studies patients have been elected for ELD on 
the basis of a negative tap test (117;118), making the sensitivity of the ELD probably 
underestimated. However, the positive predictive value, judging from these studies, as well 
as studies by Malm et al (65), McGirt et al (53) and Marmarou et al (41), is considered to be 
high, probably averaging 85% (116). The complication rates are ranging from 5 to 20% 
(118;121;122). In many centers, ELD is considered the gold-standard of recruiting patients 
for surgery. ELD requires, however, that the patients are hospitalized for several days in 
highly specialized departments, and it is therefore a cost-demanding procedure. As with the 
tap test, a general problem is the lack of universally applicable criteria for improvement. 
1.6.4. Cisternography 
The procedure consists of injecting an isotope (usually 131I-labeled serum albumin or IN-
111 pentetate) into the lumbar subarachnoid space, and performing subsequent intermittent 
gamma-imaging during 24 or 48 hours. Ventricular reflux and delayed ascent over the 
cerebral convexities were supposed to be the hallmarks of the NPH-patient. This procedure 
is still used in some, albeit few, centers. The only clinical study to assess the prognostic 
value concludes that cisternography do not improve the diagnostic accuracy of combined 
clinical criteria and CT-criteria (123). 
1.6.5. Hydrodynamic measurements 
The lumbar infusion test was originally described by Katzman and Hussey (124). In the 
Katzman infusion test, an isotonic solution is infused at a constant rate via a needle placed 
in the lumbar subarachnoid space (see also section 3.2.1). Traditionally, the resistance to 
outflow (Rout) is defined as the difference between the reached plateau level of pressure and 
the opening pressure, divided by the infusion flow rate. Several other infusion methods 
exist, including the bolus method (125), the constant pressure method (65) and the 
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ventriculocisternal method (126). Most studies have been conducted using variants of the 
original Katzman test, which generally produces higher values of Rout (116). Several studies 
have addressed the predictive value of Rout (43;65;109;120;126;127). The results, as to 
prediction of outcome after shunting, are very diverging, probably reflecting center- and 
examiner-specific variations, different diagnostic and clinical criteria, as well as the fact that 
many series have not differentiated between iNPH and sNPH. Thus, two systematic reviews 
have concluded that the results are center-specific, one citing that the only class II 
prospective study (65) found marginal sensitivity, specificity and positive predictive value 
(116), the other concluding that the use of Rout determination has “questionable value” (36). 
The value of measurement of the single wave pressure amplitude from the lumbar infusion 
test is discussed in detail in subsequent sections of this thesis. 
Intracranial assessments of hydrodynamic parameters have also been extensively studied. B-
waves; rhythmic oscillating increases in ICP lasting 0.5 to 2 minutes (15), are frequent in 
hydrocephalus (128-130). Several studies have reported that frequent occurrence of B-
waves predict a positive outcome of shunting (128;129;131). The identification of B-waves 
might, however, be difficult and observer-dependent (132;133). One study found that the 
lumbar puncture opening pressure had no correlation with the frequency of overnight B-
waves in hydrocephalic patients (134), and one study incorporating objective B-wave 
analysis concluded that B-waves were only weakly related to the degree of post-surgical 
improvement (135). 
The intracranial compliance can be defined as the ability of the intracranial compartments to 
accommodate a volume change (136). Intracranial compliance is significantly decreased in 
both acute and chronic hydrocephalus (137-140), as well as in normal aging (139). This
reduces the ability of the brain to dampen arterial pulse pressure waves (137), and 
experimental and clinical studies have shown high pulsatility in the ventricular CSF of 
hydrocephalic patients (141-145). Studies have also shown that single ICP wave amplitudes 
probably more reliably predict intracranial compliance than mean ICP alone (146;147). The 
importance of these observations is further detailed in subsequent sections of this thesis. 
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1.7. Selection of patients for surgery 
Surgical treatment options in NPH-patients include placement of a CSF-diverting shunt 
from the cerebral ventricles to either the peritoneum (ventriculoperitoneal (VP)-shunt) or the 
atrium (ventriculoatrial (VA)-shunt), a CSF diverting shunt from the lumbar subarachnoid 
space to the peritoneum (lumboperitoneal (LP)-shunt) and endoscopic third 
ventriculostomy. There are insufficient data to show an advantage or disadvantage of 
ventricular versus lumbar shunt placement (148). There is one retrospective study 
comparing VA- and VP-shunts in hydrocephalic patients, finding no difference in 
complication rates (149). A recent multicenter study showed that endoscopic third 
ventriculostomy might be effective in iNPH (150), but a wider use of this procedure is still 
not advocated in NPH-patients (151), still making a VP- or VA-shunt the mainstay of 
surgical treatment (148). Interestingly enough, no randomized controlled trial has yet 
assessed whether placement of a shunt is effective in NPH, as shown by a Cochrane review 
(152). 
A single standard for the prognostic evaluation of NPH patients does not exist. From the 
discussion in sections 1.2.4 and 1.6, it is clear that the selection of the individual patient for 
surgery must rely on information from multiple domains. In line with this, a review 
indicated that maximum 50% of patients with clinical and radiological iNPH respond to 
shunt treatment (36), showing that supplemental tests to help identify patients who will 
respond favourably to shunting are needed. The Guidelines for the diagnosis and 
management of iNPH from 2005 thus recommended a five step procedure, aiming at a 
degree of certainty for improvement of >80%. This procedure incorporates clinical 
evaluation, supplemental testing in the form of CSF-tap test and/or determination of Rout
and, in cases of subsequent doubt, ELD (116).
As outlined in sections 1.6.1 through 1.6.5, no single test can to date predict with a high 
both positive and negative predictive value who will benefit from shunting. This adds to the 
fact that the clinical features alone likewise are not able to predict the shunt response, as 
shown in sections 1.2.1 through 1.2.4. The lack of a single uniform prognostic test and/or 
clinical feature is reflected in the fact that practice to confirm the diagnosis and to select 
patients for surgery varies widely (36;153). 
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The key symptoms of iNPH, problems with gait, urinary continence and cognition, are 
abundant in the elderly, and are rather indeterminate. Studies have shown that patients 
having potentially shunt-responsive iNPH can present with only one or two of the symptoms 
in the clinical triad (42;80), and that a variety of symptoms can be associated with the 
condition (49;50;154-156). The lack of epidemiological data concerning the occurrence of 
iNPH therefore also poses a problem when trying to select patients for both diagnosing and 
treating iNPH. 
As previously stated, using the degree of shunt response as a diagnostic criterion for iNPH 
is problematic and can be viewed as something of a tautology. When selecting patients for 
surgery, one must therefore bear in mind that there is an obvious difference between 
diagnosing iNPH per se on the one hand, and predicting who will benefit from shunting on 
the other. Considering the age group in question, some patients will have co-morbid 
conditions hampering an otherwise good clinical response from shunting. Furthermore, the 
pathological process might have progressed to a stage where the patient is refractory to 
treatment (116). These features point to the need for careful interpretation when assessing 
shunt response rates from clinical studies. 
For the practicing neurologist facing patients in whom iNPH might be a possible differential 
diagnosis, all the above mentioned aspects are a source of confusion: In whom, and how 
often, should I consider the possibility of iNPH? How should iNPH be diagnosed? Which 
patients should be referred to surgical treatment? 
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2. Aims of the thesis
The aims of the thesis were as follows: 
 To estimate the epidemiology of iNPH in a Norwegian population compared to the 
incidence of surgery for the condition. 
 To assess whether lumbar measurements of cerebrospinal fluid pressure concurs 
with intracranial measurements, and with the clinical response to shunting. 
 To assess which of the lumbar hydrodynamic measurements that best can predict the 
clinical response to shunting. 
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3. Methods
3.1. Epidemiology 
3.1.1. The Vestfold study of iNPH (Paper I) 
Patients from the Norwegian county of Vestfold were included in this study. Starting two 
months before the 12 months inclusion phase, we actively and systematically informed 
about iNPH to all the county’s institutions and health practitioners. They were asked to refer 
“any patient, irrespective of age, having a history of at least three months of gradually 
increasing gait and/or balance problems with concomitant subjective impairment in 
cognition and/or urinary symptoms” (Paper I). We also aimed to inform the public, using 
entries about iNPH in local newspapers, radio shows, news broadcasts, and the local 
television channel.  
All patients underwent detailed neurological clinical assessment performed by the main 
investigator (AB), and were included if they fulfilled the following criteria: “A history of at 
least three months, not entirely attributable to other conditions, of gradually increasing 
disturbance in gait and balance with concomitant urinary incontinence or urgency and/or 
subjective cognitive impairment as experienced by patient and/or family” (Paper I).
All patients underwent CT or MRI to assess the existence of ventricular enlargement. In all 
the included patients, a lumbar puncture was performed, followed by a lumbar infusion test.
The patients were retrospectively classified into the categories Probable, Possible or
Unlikely iNPH, using the Guidelines for the diagnosis and management of iNPH (42).
The prevalence and incidence rates were calculated using the population figures for 
Vestfold and Norway from Statistics Norway’s StatBank (157). The study was approved by 
the Norwegian social science data services and by the Regional Committee of Ethics.
A search was performed in MEDLINE, identifying papers with the term “normal pressure 
hydrocephalus”, combined with the terms “epidemiology”, “prevalence” and “incidence”.
EMBASE was likewise searched, looking for papers with the subject heading 
“normotensive hydrocephalus” and the subheading “epidemiology”. In relevant studies 
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(26;68;71;153;158) the reference lists were examined, looking for additional relevant 
studies. 
3.1.2. The national incidence of surgery for iNPH (Paper II) 
In Norway’s five neurosurgical regional centers, the authors of this paper personally 
collected information about all patients who, during the period from 2002 to 2006, had been 
“hospitalized with any diagnosis of iNPH and operated with insertion of a ventriculo-
peritoneal or ventriculoatrial shunt system, or with endoscopic third ventriculostomy”
(Paper II). The patients were identified by using the computerized patient journal registry at 
each center, automatically searching for the relevant diagnostic codes and operation codes. 
To verify the diagnosis of iNPH, a manual search was performed by the authors at each 
center and in all patient records. The placement of a shunt system or the performance of a
third ventriculostomy was also verified. Patients who only underwent shunt revisions were 
excluded. Information about age, sex, operation year and operation type were collected. The 
Norwegian social science data services approved the study. The Regional Committee of 
Ethics was informed, and had no objections to the study. Prevalence and incidence rates 
were calculated using population data from Statistics Norway’s StatBank (157). 
3.2. Methods of assessment 
3.2.1. The concurrence of lumbar CSFP with ICP (Paper III) 
Lumbar CSFP and ICP data were collected from 27 consecutive iNPH patients. Overnight 
ICP monitoring was performed, followed by a lumbar infusion test, in which simultaneous 
recordings of lumbar CSFP and ICP were taken. Raw data were sampled at 100 or 200 Hz, 
and stored on a computer server. They were analyzed retrospectively, using a method 
previously described (159-161). This method includes software that automatically detects 
pressure peaks and valleys, based on the units “with” (time in seconds) and “threshold” (ICP 
in mmHg). For details regarding the calculations applied in this software, see reference 160. 
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This method automatically identified the cardiac-beat induced pressure waves, removing 
pressure waves caused by artifacts in the pressure signals due to noise. Simultaneous 
pressure waves in the lumbar CSF and the intracranial compartment obtained during 
infusion were then compared (162). The pulse pressure amplitude, latency and mean single 
wave pressure were computed for every cardiac beat-induced single pressure wave (159-
161).
In consecutive 6-seconds time windows, mean lumbar CSFP wave amplitude and mean ICP 
wave amplitude, as well as mean values of mean single wave pressure (i.e. mean lumbar 
CSFP or mean ICP) were computed (159;160).  
The lumbar CSFP-resistance to CSF outflow (CSFP-Rout) and the ICP-resistance to CSF 
outflow (ICP-Rout), were computed for each lumbar CSFP and ICP recording during lumbar 
infusion testing (163;164).
Agreement between average values of mean CSFP wave amplitude and mean ICP wave 
amplitude, mean CSFP and mean ICP, and between CSFP-Rout and ICP-Rout were examined 
and determined using a Bland Altman plot (165).
We also examined whether elevated lumbar mean CSFP wave during lumbar infusion could 
predict elevated mean ICP waves during long-term, overnight ICP monitoring. We defined 
lumbar mean CSFP wave amplitudes as elevated when they were “either >7 mmHg in 60% 
of time, >8 mmHg in 30% of time or >9 mmHg in 10% of time” (Paper III), and mean ICP 
wave amplitudes as elevated when they were “either >4 mmHg in 70% of time, >5 mmHg 
in 40% of time or >6 mmHg in 10% of time” (Paper III).  
3.2.2. The concurrence of intraparenchymal pressure with intraventricular 
pressure (Paper IV) 
The study presented in Paper IV was undertaken to explore whether pressure signals 
obtained from the ventricular CSF and the brain parenchyma gave comparable results, as 
related to identification of cardiac-beat waves. This study used the same sensors as used in 
the papers III, V and VI.  
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The intracranial measurements were performed on a 48-year-old man with subarachnoid 
hemorrhage (SAH) from a left middle cerebral artery (MCA) aneurysm. He was treated in 
the intensive care unit, The National Hospital, Oslo, were he immediately after arrival 
received an external ventricular drainage (EVD) and an ICP-sensor along this drainage. The 
day after arrival, he underwent craniotomy and aneurysm clipping. He was extubated and 
awakened the subsequent day. 
The EVD was left in place during the next few days, during which simultaneous ICP 
monitoring from the CSF and the parenchyma (PAR) was performed intermittently. The 
EVD was closed for CSF drainage during the CSF/PAR pressure monitoring. 
3.3. Selection of patients for surgery 
3.3.1. The lumbar infusion test and clinical response to shunting (Paper V) 
During a period of 12 months, all patients referred for suspected iNPH to the County 
hospital of Vestfold, Norway, were included in this study. The algorithm for patient 
management is described in section 3.1.1, as well as in further detail in Paper I. Patients 
were categorized into either Possible or Probable iNPH (42).
A NPH grading scale was used to clinically grade all patients and evaluate outcomes (166).
This grading scale assesses gait disturbance, dementia and urinary incontinence, each 
ranging from 1 to 5, giving a total range from 3 to 15. All patients had a CT or MRI of the 
brain, and a standardized lumbar infusion test. The resistance to CSF-outflow (Rout) was 
determined from the variables opening pressure (Po) before infusion and plateau pressure 
(Pp) during infusion. The Rout was calculated as  (Pp – Po)/infusion rate (125), see also 
section 1.6.5.
The CSFP pulsatility (CSFP-Qpulse) was calculated retrospectively as described in section 
7.2.1, and the mean CSFP wave amplitude was computed
Patients with Possible or Probable iNPH and Rout> 10 mmHg/ml/min, were referred to the 
Department of Neurosurgery, The National Hospital. According to this departments own 
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routines (167), some of the patients were selected for surgery, and received an extra-cranial 
programmable valve shunt with opening pressure 10-14 cm H2O.
Neurological assessment was performed in all shunted patients, and in a subgroup of 12 age- 
and sex-matched non shunted patients, after 12 months. 
The regional human research committee and the Norwegian social science data services 
approved the study.  
3.3.2. The lumbar infusion test versus ICP and clinical response to shunting 
(Paper VI) 
All patients who had been examined for suspected iNPH with over-night ICP monitoring 
and lumbar infusion testing in the Department of Neurosurgery, The National Hospital, 
Norway, from 2002 until 2007 where included in this study. The criteria for surgical 
treatment (implantation of a VP-shunt) were as described in an earlier paper (168), and 
consisted of a combination of clinical and radiological observations and ICP monitoring.
The patients had their first follow-up after three months, and the shunt response was 
evaluated after 12 months. CSFP was determined as the average of CSFP wave amplitude 
during the opening phase after lumbar puncture, and as the average of CSFP wave 
amplitude during 10 minutes of infusion at a rate of 1.5 ml/min.
The study was approved by the local hospital authorities, as well as by the Norwegian 
Social Science Data Services. The Regional Committee for Research Ethics was informed,
and had no objections.  
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4. Results
4.1. Epidemiology 
4.1.1. The Vestfold study of iNPH (Paper I) 
Eighty-six patients were admitted to the study. 81 out of these were included. Nine out of 
the 81 had no urinary or cognitive symptoms; and eight had other conditions explaining 
their symptoms. In 63 patients, neuropsychological and radiological assessment as well as 
lumbar puncture was performed. Lumbar puncture was not technically possible in one 
patient. 
The diagnostic criteria of Probable iNPH were fullfilled in 48 patients; 25 men and 23
women. The prevalence of this diagnosis then was 21.9/100,000. On the time of inclusion, 
12 out of these 48 patients had had their symptoms for less than one year. The incidence 
could thus be calculated to 5.5/100,000/year. 
The diagnostic criteria of Possible iNPH were fulfilled by all the 63 patients. Hence, the 
prevalence could be calculated to 28.7/100,000. Out of the 63 patients, 16 had had their
symptoms for less than one year, Hence, the incidence could be calculated to 
7.3/100,000/year. 
The prevalence of iNPH showed age dependency. In the age group >65 years, the
prevalence of probable iNPH was 3.3/100,000.  In the age group 70-79 years, the prevalence 
was 181.7/100,000. In the age group < 80 years, the prevalence was 93.3/100,000.
Our literature search identified four original epidemiological studies in the field of NPH. In 
these studies, the estimated incidence ranged from 0.2 to 1.8/100,000/year, while the 
estimated prevalence ranged from 0.41% in the total population >65 years to 5.38% of the 
demented individuals in the population.
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4.1.2. The national incidence of surgery for iNPH (Paper II) 
During the five year period, 252 patients were operated. Hence, the total incidence could be 
calculated to 1.09/100,000/year, ranging from 0.84/100 000/year in 2006 to
1.47/100,000/year in 2004. There was no clear trend to whether the number of operations 
increased or decreased during the five years period. Eight ventriculostomies were performed 
in South-East. With that exception, no significant relations between sex, region, type of 
operation and yearly total number of operations could be identified. The five year incidence 
was highest in the age group 70-79 years, reaching 52.1/100,000. 
4.2. Methods of assessment 
4.2.1. The concurrence of lumbar CSFP with ICP (Paper III) 
35,532 CSFP/ICP single wave pairs were available for analysis in the 27 infusion tests 
performed in this study. Pulse pressure amplitudes of CSFP waves were lower than for ICP 
waves in the vast majority of these wave pairs, with a mean difference of –2.14 mmHg. 
Mean difference in mean single wave pressure was 1.5 mmHg, but the variation was large. 
The mean difference in latency between all CSFP and ICP wave pairs was 0.04 seconds. 
The latency values were longer for CSFP than for ICP single waves.
The mean CSFP wave amplitude and the mean ICP wave amplitude during lumbar infusion 
correlated strongly. The average values of trend plots of mean CSFP wave amplitude and 
mean ICP wave amplitude had a mean difference of –2.5 mmHg, while the mean CSFP 
wave amplitudes always were lower than the corresponding mean ICP wave amplitudes. 
The mean CSFP and the mean ICP correlated strongly, while the differences were large 
between the mean CSFP and the mean ICP during infusion. The CSFP-Rout and the ICP-Rout
during lumbar infusion testing also correlated strongly.  
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When performing Pearson correlations, we found that the CSFP-derived parameters during 
lumbar infusion and ICP-derived parameters during long-term ICP monitoring only 
correlated strongly between mean CSFP wave amplitude and mean ICP wave amplitude. 
The mean ICP wave amplitude correlated only weakly with the mean CSFP, and not with 
the CSFP-Rout. 
A multiple regression model showed that during lumbar infusion, only the mean CSFP wave 
amplitude related significantly to mean ICP wave amplitude recorded during long-term ICP 
monitoring.
The presence of elevated mean CSFP wave amplitudes was related to elevated mean ICP
wave amplitudes during long-term ICP monitoring in 21 out of the 27 lumbar infusion tests 
(78%). 
4.2.2. The concurrence of intraparencymal pressure with intraventricular 
pressure (Paper IV) 
218,589 CSF/PAR single wave pairs from this patient were analyzed. There was a marginal 
mean difference in pulse pressure amplitude between the CSF/PAR wave pairs (–0.13+1.1 
mmHg). The difference in single wave mean pressure was –0.71+6.8 mmHg, while the 
difference in latency was only -0.01+0.09 seconds. 
4.3. Selection of patients for surgery 
4.3.1. The lumbar infusion test and clinical response to shunting (Paper V) 
Eighty-six patients were referred for tentative iNPH. Lumbar infusion testing was 
performed in the 63 patients that fulfilled the criteria of Possible and Probable iNPH (see
section 3.1.1). 
The infusion test-derived parameters Rout and Qpulse related weakly in the 63 lumbar infusion 
tests. Rout could not predict which lumbar infusion tests that had abnormal CSFP-Qpulse. Rout
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and percentage of 6-s time windows with mean CSFP wave amplitude being either >5 
mmHg, >6 mmHg, >7 mmHg, >8 mmHg or >9 mmHg correlated significantly, but Rout was 
not predictive for which lumbar infusion tests that had abnormal CSFP-Qpulse.  
Abnormal hydrodynamics during lumbar infusion was shown only in some of the patients 
with Possible and Probable iNPH. Between the two groups, the levels of Rout and CSFP-
Qpulse were not significantly different. No significant correlation was found between clinical 
severity and lumbar infusion test results, between Rout and total NPH score, or between 
Qpulse and total NPH score. 
Continuous over-night ICP monitoring showed abnormal ICP-Qpulse in 23 of the 32 patients 
referred to neurosurgery (72%). 20 out of these 23 patients were shunted, while three 
rejected shunt treatment The shunted and the non-shunted patients did not differ in baseline 
characteristics. 
Shunt treatment had a 15% complication rate in this material. 3 patients were dead at the 
time of neurological follow-up after 12 months. None of these died of causes related to 
management. 16 out of the 18 shunted patients (89%) had improved neurologically at the 12
months follow-up. The non-shunted patients were unchanged or worse.  
Shunt response was highly related to CSFP-Qpulse during lumbar infusion, but not to Rout. No 
correlation between Rout and change in NPH-score was found after 12 months, but CSFP-
Qpulse during lumbar infusion and change in NPH score after 12 months correlated 
significantly. Spearman’s correlations were significant for change in NPH score versus 
percentage of 6-s time windows with mean CSFP wave amplitudes ≥5 mmHg, ≥6 mmHg, 
and ≥7 mmHg in the shunted patients. 
Clinical improvement was not related to the presence of co-morbidity. After 12 months, all 
patients with abnormal preoperative CSFP-Qpulse had a very significant shunt response. A
very good shunt response was also present in five of the patients with normal CSFP-Qpulse
during lumbar infusion. An abnormal ICP-Qpulse during continuous ICP monitoring was 
present in all these. Lumbar infusion testing hence did not reveal abnormal pulsatility 
predictive of clinical improvement after shunting in 5 out of 32 patients (16%). 
Only one out of the 17 patients that had abnormal ICP-Qpulse during ICP monitoring did not 
improve in NPH-score after 12 months. This patient was later diagnosed with progressive 
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supranuclear palsy. Thus, quantification of the ICP pulsatility (ICP-Qpulse) was more 
strongly related to change in NPH-score than the results of infusion testing. 
4.3.2. The lumbar infusion test versus ICP and clinical response to shunting 
(Paper VI)
A total of 62 iNPH patients were included, and underwent lumbar infusion testing the day 
following over-night ICP monitoring. There were minor complications from diagnostic ICP 
monitoring in 4 of 62 patients (6.5%). No patients had complications from the lumbar 
infusion test. 
All patients had a normal static ICP, while ulsatile ICP was elevated in 42 of 62 patients 
(68%) during over-night ICP monitoring. Pulsatile CSFP was low in 17 out of these 42 
patients during the opening phase of lumbar puncture, but low in only 5 subjects during 
infusion.
Shunting was performed in 45 patients. 78% were shunt responders. 18% had major 
complications after shunting. 13% had minor complications. 44 out of the 45 patients had an 
Rout >12 mmHg/ml/min. Rout and clinical improvement 12 months after shunting correlated 
weakly, but significantly. 
Clinical improvement 12 months after shunting and pulsatile ICP recorded over-night 
correlated highly significant. Clinical improvement did not, however, correlate with the 
pulsatile CSFP during the opening phase after lumbar puncture. Change in NPH score after 
12 months and pulsatile CSFP measured during lumbar infusion correlated significantly. 
Shunt responders and non-responders were differentiated by the CSFP pulse during the 
opening phase after lumbar puncture. They were even better differentiated by the CSFP 
pulse during infusion, and best differentiated by the over-night ICP-monitoring. 
Predicting shunt response from the pulsatile ICP recorded over-night, and from pulsatile 
CSFP during lumbar infusion both gave high positive and negative predictive values (PPV 
and NPV). 
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5. Discussion
5.1. Epidemiology 
5.1.1. The Vestfold study of iNPH (Paper I) 
As discussed in the paper, having only one neurological and one neurosurgical department 
to serve the Vestfold County makes it highly possible that there has been no leakage of
patients to other hospitals, especially since all the counties that surround Vestfold admit 
their neurosurgical patients to the National Hospital as well. As shown in the paper, 
Vestfold County did not differ from the rest of Norway on a few major parameters. The 
ethnic homogenicity and high geographical mobility in Norway also adds to the high 
probability that the findings in the study can be extrapolated to the whole of Norway. 
Nevertheless, one must bear in mind that the etiology of iNPH is unknown, extrapolating 
the findings to populations in other parts of the world must therefore be done with care.
The study was population based, accepting patients directly from homes and nursing homes. 
This is not the case with most of the few other epidemiological studies that has been 
performed in this field. The study by Vanneste et al (68) was retrospective, including only 
patients admitted to neurosurgical centres and treated with shunt insertion. Using these 
criteria, and furthermore including only patients who also had a good response from their 
shunt insertion, they calculated an incidence of 2.2/million/year. Using this design, the 
prevalence could not be estimated. Krauss and Halve’s study (153) was a questionnaire 
survey of 82 neurosurgical centres in Germany, out of which 65% responded. The estimated 
annual incidence of NPH was 1.8/100,000. It is not clearly defined in the questionnaire 
whether shunt insertion and shunt response was necessary to confirm the diagnosis, and the 
diagnostic criteria varied from centre to centre. 
In contrast to these two neurosurgical materials stands Trenkwalder et al’s study from 1995, 
where 982 out of a total population of 1192 inhabitants over the age of 65 years in two 
German villages were examined for Parkinsonism (158). A total of 45 showed clinical signs 
of Parkinsonism (i.e. basal ganglia signs). Out of these, 4 patients were diagnosed as having 
NPH, making the prevalence in this study 0.41% in the age group over 65 years of age. In 
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contrast, the prevalence of iNPH in our study was 0.12% in the age group over 65 years of 
age (117.8/100.000). The diagnostic criteria in Trenkwalder et al’s study, however, varied 
sligthly from ours, including “typical gait disorder, bladder incontinence, dementia to a 
variable extent, and corresponding periventricular lucencies with ventricular enlargement”.
The patients in Trenkwalder et al’s study were 76, 82, 84 and 89 years of age, i.e. somewhat 
older than our patients, but a further analysis of differences between the two patient 
materials is not warranted because of the low absolute number of patients. It is worth noting, 
though, that one of the prerequisites for referral to our project was “gradually increasing 
symptoms”, something that a priori probably would have excluded at least two out of the 
four patients in Trenkwalder et al’s material, because they had had their symptoms for many 
years at the time of inclusion. 
In Vale and Miranda’s study from 2002 (71), 168 patients with dementia, all admitted to a 
tertiary-care outpatient clinic in Brazil from 1997 to 1999, were examined 18 months after 
their initial assessment. It is stated that all patients underwent CT and/or MRI, but the 
results of these examinations are not stated. The authors reported that 10 patients (5.4%) had 
NPH. The diagnostic criteria for this, however, is not stated, neither whether they showed 
the clinical triad, nor whether they showed ventriculomegaly on the radiological 
examination. 
In summary, Trenkwalder et al’s study (158) is the only study that can be said to have a 
strictly population based methodology. This methodology would theoretically yield a 
somewhat higher prevalence than our methodology because it is more strictly population 
based and not relying on referral of patients. This concurs with the fact that this paper 
reports a higher prevalence than ours. We found a total of 10 patients living in the county of 
Vestfold that had previously been shunted for iNPH. These patients were not included in the 
material since we did not have sufficient preoperative data to classify them according to our 
criteria. If, theoretically, these patients were included in our population figures, this would 
yield a prevalence of 0.17% in the age group over 65 years of age, something which still is 
below Trenkwalder et al’s prevalence numbers. Still, Trenkwalder et al’s primary inclusion 
criteria of Parkinsonism could theoretically lead to an underestimation of NPH, because 
Parkinsonism is not a primary trait in NPH. It is also worth noting that Trenkwalder et al’s
paper, Vanneste et al’s (68) paper and our paper, are the only three to have a clear definition 
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of NPH as basis for the epidemiological estimates. Not surprisingly, comparison between 
these three publications shows an inverse relationship between the narrowness of the 
inclusion criteria and the occurrence of NPH reported. 
Our methodology differs from a strict population-based methodology since the total 
population was not examined systematically. A strictly population based approach would, 
however, raise dificulties: Given the probable prevalence range of NPH, one would have to 
clinically assess several thousands of inhabitants to reach a fair number of NPH-patients, 
something that would neither be practically nor ethically feasible. 
We applied wider primary inclusion criteria than any of the abovementioned studies, except 
Vale and Miranda (71), who did not report any inclusion criteria in their study, nevertheless 
only 86 out of nearly 220,000 inhabitants were admitted to our study. This might have 
several explanations, as elaborated on in the “Discussion” section of the paper (Paper I).
63 patients in our material underwent lumbar puncture as part of the diagnostic evaluation. 
59 out of these had an opening pressure between 5 and 18 mmHg, which is the 
physiological criterion for the diagnosis of “Possible iNPH” according to the cited criteria 
(42). The four patients in our material that did not meet these criteria all had opening 
pressures below 5 mmHg (unpublished figures). The reason for having the upper limit of 18 
mmHg is obvious, since high opening pressures are more indicative of acute or secondary 
forms of hydrocephalus (42). The reason for having the lower limit of 5 mmHg, however, is 
not evident. The Guidelines cite no scientific evidence suggesting that a low opening 
pressure is incompatible with the diagnosis of iNPH. Few studies report details about the 
opening pressure of iNPH-patients. In the Dutch NPH-study, the 101 patients were reported 
to have a baseline CSF-pressure mean of 11.2, with a standard deviation of 3.3 and a range 
from 5 to 20 mmHg (43). However, they do not report significant correlation between the 
opening pressure and degree of shunt response. Neither do any other of the large series of 
iNPH-patients. It is therefore, in my opinion, dubious whether patients with an opening 
pressure of for instance 3 or 4 mmHg should be any less likely to have the condition than 
patients with an opening pressure of 5 mmHg, However, if we had included the four patients 
with a lower opening pressure in our study, this would not have made any practical 
difference, since none of them anyhow complied with all the other criteria for the diagnosis. 
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It is important to notice that our study reports the occurrence of “Probable” and “Possible” 
iNPH (42), and not the occurrence of shunt responsive NPH. No study has thus far assessed 
the rate of shunt response when using these diagnostic criteria. 32 out of the patients in our 
study were referred to neurosurgery (see paper V in this thesis). Continuous over-night ICP 
monitoring showed abnormal ICP-Qpulse in 23 out of these (72%). 20 were shunted, and out 
of the 18 who was available for 12 months follow up, 16 had improved neurologically (see 
paper V, as well as section 7.3.1 of this thesis). The study was not designed as to test how 
well the guidelines are able to foresee shunt responsiveness. No clear conclusion can hence 
be drawn from this, except for the fact that at least some of the patients who fulfill the 
diagnostic criteria of “Probable iNPH” will profit from shunt treatment.
After the publication of our study, a Japanese retrospectively analysed community-based 
study of 170 community dwelling subjects of > 75 years of age has been published (105). In 
this material, 2.9 % showed radiological and clinical features consistent with iNPH.  The 
authors in this study did not, however, perform lumbar puncture. The diagnostic criteria 
used were the diagnostic iNPH-criteria from the Japanese Society of NPH (169), and not
the same guidelines that were used in our study (42). Another recent Japanese study 
randomly selected 567 individuals from among 1654 members of a rural population aged 65 
years and older. They found that the prevalence of “possible iNPH” (42) was 1,4 %. These 
studies again illustrate the need for more uniform diagnostic definitions in this field of 
study, and therefore the importance of internationally accepted guidelines. It also illustrates 
the need for further epidemiological studies both related to the epidemiology of the 
condition by itself, and to the response to shunt treatment. 
5.1.2. The national incidence of surgery for iNPH (Paper II) 
As described in section 3.1.2, the data in this study were collected by using the 
computerized patient journal registry at each center, automatically searching for the relevant 
diagnostic codes and operation codes. As step two, a manual search was then performed by 
the authors at each center and in all patient records indicated by the computerized patient 
journal registry. In Norway’s health care system, part of the economic compensation given 
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from the health care authorities to the individual hospital is linked to the number of patients 
treated (i.e. the diagnoses of the individual patient) and to the number of surgical procedures 
performed in the hospital. Because of this system of reimbursement, the hospitals give much 
effort in keeping the data files of diagnoses and surgical procedures as complete as 
technically possible. This makes it highly possible that step one of our strategy; the use of 
the computerized patient journal registry at each center, ensured a near completeness of the 
data collected. Step two of the strategy; the manual search in every relevant patient record, 
ensured that no patient or operation was wrongly accounted for. However, this type of 
retrospective strategy has the disadvantage of being entirely reliant on correct coding at each 
center. Systematic differences in coding practice between the hospitals could theoretically 
give systematic errors in the data collected. Our results, however, showed that there were 
little differences between each regional center concerning the type and frequency of 
operations. This makes it less probable that there were any such systematic error in one or 
more of the centers. Theoretically, since the number and type of diagnoses and procedures 
have economic consequences for each hospital, the number of operations could have been 
exaggerated for economic reasons in one or more of the centers. However, our manual 
search of each relevant patient record makes it much less probable that this has happened. 
It is interesting to note that the age dependent peak five year incidence is in the age group 
70 – 79. This is consistent with our findings in Paper I, where we found the yearly incidence 
of iNPH to be twice as high in this age group compared to people older than 79 years (170). 
It is uncertain whether this reflects a true decrease in the incidence in the highest age group, 
or whether it merely reflects an age dependent selection bias in our material. 
Ventricuoperitoneal shunt was the preferred operation type at all the regional centers. On 
eight patients in the south-east region a third ventriculostomy was performed. These 
procedures could be regarded as experimental treatment; four of the eight patients later 
received a ventriculoperitoneal shunt. 
There is limited knowledge about the frequency of surgery for iNPH. In one study, the total 
incidence of surgery for adult hydrocephalus varied from 2.3 to 3.6/100 000/year between 
regions in Sweden during a three year period (107). Even though the study was not designed 
to study the incidence of operations for iNPH alone, iNPH was listed as cause for operation 
in 243 out of a total of 891 operations, making it possible to calculate an incidence of 
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operation for iNPH of 0.91/100 000/year, which is quite similar to the findings in our study. 
It is somewhat surprising that the incidence of surgery for iNPH seems to be quite similar 
both between different Norwegian regions, as shown in our study, and between two nordic 
countries, as shown in this Swedish study as compared to our study. This is in spite of the 
lack of uniform guidelines both for diagnosing iNPH, and for choosing which patients to 
operate. One explanation for this could be that this reflects the true incidence of the 
condition, i.e. that since the incidence and prevalence of the disease is stable between 
regions and neighboring countries, then this is reflected in a stable incidence of surgery. 
However, data from Paper I in this thesis suggest that there is a minimum incidence of iNPH 
of 5.5/100 000/year in Norway, while Paper II showed a total incidence of surgery for iNPH 
of 1.09/100 000/year. As previously noted, one must bear in mind that Paper I did not report 
the incidence of shunt-responsive iNPH, but the incidence of “probable iNPH” (42). How 
many of these patients who would profit from insertion of a shunt is unknown, as prediction 
of shunt-response is difficult, probably depending also on independent factors such as age 
and duration of symptoms (31;42;148). Degree of co-morbidity has in a recent article also 
been shown to be a significant predictor of the quality of clinical outcome after shunt 
insertion (171). Even with these reservations, there is an obvious discrepancy between the 
probable incidence of the condition and the incidence of surgery for the condition. There are 
several possible explanations for this discrepancy: Firstly, the syndrome of iNPH is 
generally little known to the public, as opposed to many other afflictions of the elderly. 
Secondly, the syndrome is probably also generally little known among many general 
practitioners and other health care workers. There is evidence to suggest this, as the 
information campaign we conducted in Vestfold, Norway in the Vestfold iNPH-study 
(Paper I, see section 3.1.1) gave 86 referrals and resulted in a total of 20 shunted patients in 
one year (Paper V, see section 4.3.1), as opposed to a total of 18 shunted patients from the 
same region during the previous 10 years (Paper I). Thirdly, the symptoms of iNPH (gait 
problems, urinary incontinence and dementia) are abundant in the elderly. This means that 
even when given knowledge about the existence of the syndrome, it is not necessarily 
evident for neither patients nor health care workers when and whom to refer. Connected to 
this is also the fact that iNPH mostly affects an age group where unspecified, insidious 
symptoms often are considered inevitable or even part of normal aging (a shuffling gait 
might for instance be taken as part of normal aging, and not as part of a treatable syndrome). 
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The lack of universally accepted guidelines for diagnosing iNPH, and the lack of powerful 
tests to predict shunt success in the individual patient, probably also contributes to the 
relative low rate of surgery. 
5.2. Methods of assessment 
5.2.1. The concurrence of lumbar CSFP with ICP (Paper III) 
An interesting observation in this study was that the intracranial pulse pressure amplitudes 
increased more than the corresponding lumbar cerebrospinal fluid pulse pressure amplitudes 
during lumbar infusion. In absolute numbers, the lumbar cerebrospinal fluid pulse pressure 
amplitude values were about 2 mmHg lower than the intracranial pulse pressure amplitudes. 
We hypothesize that this might be due to differences in compliance between the lumbar 
CSF and intracranial compartments. Since a previous study has showed that that the pulse 
pressure amplitudes increase when intracranial compliance declines (172), the raise in pulse 
pressure amplitude may represent the pressure response to the increase of intradural volume 
during lumbar infusion. A less increase in the lumbar cerebrospinal fluid pulse pressure 
amplitudes may therefore indicate that the compliance capacity is higher within the lumbar 
CSF compartment than within the intracranial compartment. This might in part be an 
example of a “windkessel effect”, as seen in many pulsating biological flow systems.
Nonetheless, a previous study has given evidence indicative of that the spinal compartment 
contributes only about one third of the total spinal/cranial compliance capacity (173). Even 
though this observation is not incompatible with our observation of the lower amplitudes in 
the spinal compartment as compared to the intracranial compartment, further studies must 
clarify the distribution of compliance capacity within the intrathecal compartments. 
Our observation could also have been explained by the existence of a pressure gradient 
between the CSF and the brain parenchyma wherein ICP is measured. Even though this 
possibility cannot be excluded, we were in Paper IV in this thesis not able to demonstrate 
such a pressure gradient between ventricular CSFP and ICP (162). 
There was a larger variation between the lumbar CSFP and ICP mean single wave pressures, 
and also a larger variation between mean CSFP and mean ICP. Even though we took care to 
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keep the CSFP and ICP sensors at the same height level during lumbar infusion testing, one 
must bear in mind that the mean pressure is relative to the atmospheric pressure. A
difference in the height level between the lumbar and intracranial sensors might therefore 
yield false differences in the pressures measured due to differences in baseline pressure 
(161). 
In contrast to this, pulse pressure amplitudes are relative values not relating to, or dependent 
on, the atmospheric pressure, since they measure the difference between the minimum 
diastolic and the maximum systolic pressures. The pulse pressure amplitudes are therefore 
not dependent on the baseline pressure. 
The strong correlations between lumbar CSFP- and ICP-derived parameters during lumbar 
infusion concur with previous data regarding mean CSFP/mean ICP and CSFP-Rout/ICP-Rout
(163), and with previous data showing a correlation between lumbar CSFP-Rout and mean 
ICP (174). A significant correlation between lumbar cerebrospinal fluid pulse pressure 
amplitude and mean pressure during lumbar infusion testing have also been shown by others 
(175), and the mean difference of 2.4 mmHg/ml/min between lumbar CSFP-Rout and ICP-
Rout during lumbar infusion testing is also in line with previously reported data (163).  
The strong correlations between lumbar CSFP- and ICP-derived parameters during lumbar 
infusion do not necessarily imply a correlation to ICP-derived parameters recorded during 
long-term, overnight ICP monitoring, since this is a different physiological situation. Hence 
lumbar CSFP-Rout has not been shown to predict ICP during long-term overnight 
monitoring, neither in iNPH (163) nor in children (176). Similarly, in one of the other papers 
in this thesis, neither lumbar CSFP-Rout nor mean CSFP during lumbar infusion were related 
to the parameters mean ICP and mean ICP wave amplitude derived from long-term, 
overnight ICP monitoring (Paper III, see section 4.2.1). In the same paper, it is shown that 
there is a strong correlation between mean CSFP wave amplitudes during lumbar infusion 
and mean ICP wave amplitudes during long-term ICP monitoring. When using the threshold 
levels of mean CSFP wave amplitudes (164) and mean ICP wave amplitudes (166) 
previously determined in the Neurosurgical Department, The National Hospital, it was 
previously found that elevated lumbar mean CSFP wave amplitudes were associated with 
elevated mean ICP wave amplitudes during long-term ICP monitoring in 21 of 27 lumbar 
infusion tests (78%),.  
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For the purpose of determining to which extent the CSFP amplitudes recorded during 
lumbar infusion can predict the intracranial pulse presssure amplitudes during long-term 
ICP-monitoring, this material of 27 patient recordings was rather small. Paper VI in this 
thesis elaborates further on how the CSFP pulse amplitude during lumbar infusion testing 
concurs with the intracranial pulse pressure amplitudes during long-term, overnight ICP 
monitoring (see section 8.3.2).
5.2.2. The concurrence of intraparenchymal pressure with intraventricular 
pressure (Paper IV) 
Even though this paper reports only one case, more than 118 000 CSF/PAR wave pairs were 
recorded and analyzed, showing that there were marginal differences in single wave
parameters when ICP was monitored continuously both within the ventricular CSF and the 
brain parenchyma,.  
Previous papers have extensively tested that the single wave identification algorithm has a 
correct wave detection (160;161). 
As already commented on in section 8.2.1, the pulse pressure amplitudes constitute the 
pressure difference between diastolic minimum and systolic maximum pressures. As such, 
this parameter is independent of the baseline pressure or the zero pressure level calibration 
of the pressure transducer. 
In contrast, the mean pressure parameters, including the mean single wave pressure, are 
relative to the atmospheric pressure. Since zero calibration for the ICP sensor in the brain 
parenchyma takes place in the operating theater, subsequent mean pressures are relative to 
the zero pressure level at the time of implantation. On the other hand, CSF pressure 
monitoring allows zero calibration against atmospheric pressure at anytime, but baseline 
pressure is heavily affected by the placement of the sensor relative to the distal end of the 
EVD.  
These considerations taken into account, the marginal difference in CSF/PAR pulse pressure 
amplitudes suggests a marginal pressure gradient between the ventricular CSF compartment 
and the brain parenchyma. It has previously been discussed whether there is a ventricular-
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parenchyma pressure gradient which can be responsible for the enlargement of the 
ventricles in hydrocephalus, but a study published in Neurosurgery in 2002 finds no 
evidence of a transmantle pressure gradient in nonacute communicating or non-
communicating hydrocephalus (78). In line with this previous report, our case report gives 
no indication of such a pressure gradient regarding the dynamic pressure parameters. Since 
continuous monitoring of single wave pulse pressure amplitudes has been found very useful 
for neuro-monitoring, this is a significant observation (161;177).
However, our patient had a different patophysiological situation than patients suffering from 
iNPH, and also the patients in the reported series from 2002 (78). The ten patients in this 
study had communicating and non-communicating nonacute hydrocephalus. In contrast, our 
patient had a more acute form of hydrocephalus, stemming from an acute subarachnoid 
hemorrhage (SAH). The patophysiology of hydrocephalus in general is insufficiently 
known. This calls for prudency in comparing hydrodynamic measurements from different 
forms of hydrocephalus. The presence of blood in the subarachnoid space in our patient 
might theoretically also per se alter the intracranial hydrodynamics through various 
mechanisms, for example through a direct “irritative” effect on blood vessels and meninges, 
or by altering the viscosity and flow properties of the CSF. It is also worth noticing that our 
patient was somewhat younger (48 years) than the average iNPH-patient, and younger than 
the patients in the reported series from 2002 (mean 57 years, range 20-80 years) (78). 
With the abovementioned reservations, this case report showed only marginal differences in 
pulse pressure amplitude between single CSF/PAR wave pairs, and gave no evidence of the 
existence of a pressure gradient between the ventricular CSF and the brain parenchyma.  
The results of this study are important regarding the data presented in Paper III. In Paper IV 
CSFP was measured via the EVD using a Edwards fluid filled sensor, and ICP was 
measured via a solid Codman ICP sensor. In comparison, in Paper III lumbar CSFP was also 
measured using an Edward’s fluid sensor and ICP via a Codman sensor. Thus, given the 
results of Paper IV, it appears less likely that the differences in wave amplitude reported in 
Paper III are caused by different properties of the sensors used. 
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5.3. Selection of patients for surgery 
5.3.1. The lumbar infusion test and clinical response to shunting (Paper V) 
As shown in Paper I in this thesis (see section 4.1.1), 63 patients fulfilled the criteria of 
Possible iNPH (75%) and 48 patients fulfilled the criteria of Probable iNPH (57%) among 
86 patients referred to neurological work-out for tentative iNPH. As discussed earlier in this 
thesis (see section 5.1.2) how many of the patients that fulfil these criteria who will respond 
favourably to the placement of an intracranial shunt is unknown. A previous review has 
indicated that no more than 50% of patients with clinical and radiological iNPH respond to 
shunt treatment (36). This underlines the need for supplemental tests to help identify 
patients who will respond favourably to shunting (116), as discussed in section 1.7. It is 
therefore interesting that only a proportion of the 63 patients who fulfilled the criteria of 
Possible/Probable iNPH had an abnormal lumbar infusion test, and that the results of 
lumbar infusion testing were not related to the severity of iNPH. This, and the fact that the 
results of lumbar infusion testing did not associate with ventricular size as assessed by the 
Evan’s index, compares with a previous study (178).
An interesting observation is that co-morbidity did not reduce the chances of clinical 
improvement after shunting. This was somewhat surprising, and a study published later than 
this study has shown that co-morbidity can be a significant predictor of the clinical outcome 
after shunting (171). The reason for the diverging results might be that our patient material 
was rather small with regard to co-morbidity. The fact that only 20 patients were shunted, 
and that only 18 patients were available for follow up after 12 months also place limitations 
on the reliability on the other results from the study with regard to the predictability of the 
various parameters. 
Given these caveats, the Rout did not predict alterations in CSFP pulsatility (CSFP-Qpulse) in
this material. This concurs with the observation from Paper III (179). It therefore seems like 
the level of Rout is less useful for prediction of whether CSFP-Qpulse is abnormal or not. 
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As previously discussed, the static CSFP is relative to the atmospheric pressure and 
dependent on the zero pressure level, while the CSFP pulsatility is independent on these 
factors. Data from Paper III imply that CSFP-Qpulse is a better measure of the intracranial 
compliance (i.e. pressure volume reserve capacity) than the static CSFP (see section 5.2.1 
for a more thorough discussion of this). 
The results from this study confirm that patients with abnormal CSFP-Qpulse during lumbar 
infusion (164) or abnormal ICP-Qpulse during ICP monitoring (Paper III (180)) respond well 
to shunting. On the other hand, these results must be interpreted with care, both taking into 
consideration the relative low number of patients, and the fact that no patients with a normal 
ICP-Qpulse during ICP monitoring were shunted, leaving it unanswered whether these 
patients likewise could have responded well to shunting. Furthermore, all patients that were 
shunted in our study had a Rout >10, as this was the prospective selection criterion for 
referral to neurosurgical work-out. Therefore, the correlation between Rout and shunt results 
in this study only apply to patients with Rout > 10. 
One important finding is that the lumbar infusion test was false negative regarding abnormal 
pulsatility and clinical improvement following shunt in 5 of 32 tests (16%). These 5 patients 
all had abnormal pulsatility during ICP-monitoring. We therefore believe that the false 
negative infusion tests with regard to the pulsatility measures were caused by technical 
difficulties, i.e. leakage of CSF during the infusion.  
In conclusion, quantification of CSFP pulsatility (CSFP-Qpulse) during lumbar infusion 
probably improves the ability of the lumbar infusion test to predict shunt response in the 
individual patient, as compared to calculation of Rout. There remains, anyhow, a problem of 
false negative tests also with this quantification. Larger studies are needed to better clarify 
these problems, and to clarify whether the lumbar infusion test is of sufficient value in the 
assessment of iNPH-patients. Considering the low cost, easy access and few complications 
to this simple test, and considering the widespread use of the test, such studies are urgently 
needed 
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5.3.2. The lumbar infusion test versus ICP and clinical response to shunting 
(Paper VI) 
The entire experience of managing iNPH patients using diagnostic ICP monitoring in the 
pre-operative work-up during the period 2002-2007 has previously been reported (168). In 
this study, we wanted to compare this entire cohort of iNPH-patients with a subgroup from 
the cohort who also underwent lumbar infusion testing as part of the preoperative 
assessment. This subgroup of 62 patients did not differ from the entire cohort regarding age, 
sex, symptom duration, severity of symptoms, ventricular size or degree of shunt response 
(ibid).
Pulsatile CSFP was elevated in the patients who had elevated over-night ICP pulse, and 
more so during the period of infusion than during the opening phase after lumbar puncture. 
Data from Paper III in this thesis indicate that the lumbar CSFP wave amplitudes are about 
2 mmHg below the simultaneous cranial ICP wave amplitudes (see section 4.2.1). This is 
the background for the decision to categorize ICP wave amplitudes >4 mmHg as indicative
of elevated pulsatile ICP, and lumbar CSFP wave amplitude >2 mmHg as indicative of 
elevated pulsatile CSFP (179;181).
The pulsatile pressures were the focus of this study, and over-night static ICP was normal in 
all patients. Previous studies have shown that the opening pressure after lumbar puncture 
does not correlate with ICP recorded over-night (179;182;183), while lumbar mean CSFP 
agree with the ICP across a large pressure interval (184).  
The role of Rout in predicting shunt response is still highly disputed (43;65;116;181;185). In 
this series, we have considered Rout> 12 mmHg/ml/min as abnormal (116;174). 44 out of 45 
patients had an Rout> 12 mmHg/ml/min, and 35 out of these (80%) were shunt responders. 
Since a Rout> 12 mmHg/ml/min was not the criterion for shunting, one cannot conclude 
whether this parameter is predicative of the shunt response. In previous series in the 
literature, there seems to be a clear relationship between the level of Rout and the degree of 
shunt response, in the sense that a high cut-off level of Rout for accepting patients to surgery 
gives a high degree of shunt response, and vice versa. This can be exemplified by the Dutch 
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normal pressure hydrocephalus study, where a positive predictive value for a good shunt 
response was obtained in 100% of the patients for a Rout cut off level of 24 mmHg/ml/min, 
and a positive predictive value of 80% was reached for Rout cut off levels of 10 to 15 
mmHg/ml/min (43). 
In concordance with previous series (164;181), we found a highly significant correlation 
between overnight pulsatile ICP and the degree of clinical improvement seen 12 months 
after shunting, while the correlation between Rout and clinical improvement was weaker. We 
also found that the CSFP wave amplitude measured during lumbar infusion correlated with
clinical improvement after shunting, in concordance with the observations in Paper V in this 
thesis (see section 7.3.1). 
However, the results from Paper V show that clinical improvement after shunting was best 
predicted by over-night ICP (see section 4.3.1). In Paper VI, the most important observation 
is that CSFP pulse during lumbar infusion also could predict clinical improvement after 
shunting.  
Quite recently a group in Rome reported their experience of using an intraventricular 
infusion test in 120 consecutive iNPH patients over a time span of 28 years (186). This work 
especially focused on the comparison between Rout and intracranial elastance (IE), the 
reciprocal of the intracranial compliance. In this work, the IE was evaluated from measuring 
the slope of the linear regression between the diastolic ICP values and the corresponding 
amplitude of each CSF pulse pressure wave. Their results are very comparable to ours, 
showing no statistically significant difference in mean Rout value between improved and 
unimproved cases, while an IE slope value of 0.25 clearly differentiated between improved 
and unimproved cases (ibid). 
Figure 9 in Paper VI is based on the assumption that the CSFP pulse provides an indirect 
measure of the compliance (pressure-volume reserve capacity) of the intraspinal 
compartment. Reducing compliance increases the amplitudes (dP) (187). These amplitudes 
constitute the pressure response to the volume change of approximately 1 ml in the 
intracranial compartment (188) caused by each cardiac contraction.Lumbar infusion 
artificially reduces the compliance (moving to the right on the pressure-volume curve). The 
spinal pressure-volume curve is then shifted to the right compared to the cranial pressure-
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volume curve, because compliance in the spinal compartment is higher than in the 
intracranial compartment (179). It is therefore necessary to infuse fluid intrathecally to reach 
the same amplitude values in the lumbar compartment as in the intracranial compartment. 
The wave amplitudes are related to compliance, but do not constitute a direct measure of the 
compliance (189). Elevated ICP pulse is associated with reduced intracranial compliance 
(172). Shunting improves compliance, and it can be hypotesized that this is the reason why 
elevated ICP pulse measured during over-night ICP monitoring or during lumbar infusion 
can predict shunt response. 
An important technological advantage with the method used here is that an automatic 
procedure is used for identification of the cardiac beat induced waves. This quality control 
ensures that relevant and correct pressure waves are being studied. Since the intracranial 
volume change during each cardiac beat is about 1 ml (188), each cardiac-beat induced 
pressure wave can be considered a volume-pressure, created by the nature itself. As in all 
biological systems, there is some time related variation within certain limits. For this reason, 
monitoring is done for some time to obtain the average of many cardiac induced pressure 
waves to reduce the impact of time-related variation. Accordingly, when ICP monitoring is 
done for a long time, an overview of a huge number of pressure-volume tests (each cardiac 
beat induced wave being a test) is obtained. 
5.4. Concluding remarks 
It has been estimated that the number of people affected by dementia globally will double
every 20 years to 81.1 millions by 2040 (190). This will heavily affect the burden of health 
care, and underlines the need for simple and low threshold diagnostic tools in the 
assessment of cognitive decline. When evaluating tools for diagnosing iNPH, one must also 
bear this aspect in mind. 
Several of the studies in this thesis have shown a high PPV and NPV of ICP monitoring 
when assessing single wave pulsatility. This is in line with the previously cited recent Italian 
study (186), see section 5.3.2. The external lumbar drainage (ELD) is in many centres 
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considered the gold standard of the supplemental tests for iNPH, see section 1.6.3. The 
complication rates, however, are ranging from 5 to 20% (118;121;122), and ELD requires 
that the patients are hospitalized for several days in highly specialized departments. It is 
therefore a relatively cost-demanding procedure. A general problem is also the lack of 
universally applicable criteria for improvement. In line with this, the Guidelines for the 
diagnosis of iNPH reserves the ELD for step five in the recommended procedure for 
identifying shunt responsive patients (116), thus underlining the need for an easier, less 
cost-demanding test with a high PPV and NPV.
The performance of the lumbar infusion test and the performance of the over-night ICP 
monitoring represent quite different clinical settings. The lumbar infusion test can be 
performed in an out-patient neurological setting, is little resource demanding and has few 
complications. In many aspects, the lumbar infusion test can be considered a low cost, low 
threshold procedure. The over-night ICP monitoring, on the other hand, demands admission 
to a highly specialised neurosurgical department, requires in-house access to neurointensive 
facilities. It can thus, in comparison, be viewed as a high cost, high threshold procedure, 
even though the complication rate has been shown to be only 2% in a large series (191). 
As shown in section 4.3.1 (Paper V), the lumbar infusion testing, however, failed to reveal 
abnormal pulsatility and clinical improvement following shunt in 5 of 32 patients (16%), 
while the ICP-monitoring revealed abnormal pulsatility in all these 5 patients. Although it 
can be hypothesized that the false negative infusion tests relate to technical difficulties with 
the infusion test, this cannot be ascertained from the present data, and anyhow points to a 
weakness related to the procedure. Given the value of the lumbar infusion test being a low 
cost, low threshold procedure, larger studies addressing these problems are needed. Such 
studies will hopefully be able to clarify whether lumbar infusion testing with measurement 
of CSFP wave amplitudes has a role in assessment of iNPH. 
Paper V in this thesis aimed to see how infusion test results in suspected iNPH patients 
related to the clinical course and shunt response. This was done by retrospectively analyzing 
the lumbar infusion test from 63 consecutive patients with Possible or Probable iNPH (42) 
during a 12 month period. In contrast, Paper VI in the thesis assessed both diagnostic 
lumbar infusion testing and continuous over-night ICP monitoring in 62 patients during a 6-
year period. Paper VI can thus be viewed as a broadening of the perspective from Paper V, 
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adding further understanding to our experience with intrathecal hydrodynamics. It is 
important to note that the concept of “pulse wave amplitudes” used in Paper VI corresponds
to the “Qpulse” in Paper V.
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6. Conclusion and implications for further research
Paper I in this thesis reported a calculated minimum incidence of iNPh of 5.5/100 000/year 
in Norway, while Paper II showed a total incidence of surgery for iNPH of 1.09/100 
000/year during a five year period. It is important to note that Paper I did not report the 
incidence of shunt-responsive iNPH, but the incidence of “probable iNPH” (42). How many 
of these patients who would profit from insertion of a shunt remain unknown. In spite of 
these uncertainties, there is empirical support for the notion that many more patients with 
suspected NPH should be considered for shunt insertion (31). The data from Paper II 
support this view, but it is clear that further epidemiological, population based studies, also 
addressing the occurrence of shunt responsive iNPH, are needed. 
The data from Paper III showed that the lumbar CSFP pulse amplitudes recorded during 
lumbar infusion could be used to predict the ICP wave amplitudes recorded during long-
term, over-night ICP monitoring. Paper IV showed that there was no pressure gradient 
between wave amplitudes derived from brain parenchyma and ventricular CSF. Given the 
results of Paper IV, it appears less likely that the differences in wave amplitude reported in 
Paper III are caused by different properties of the different sensors used. However, the 
patient material of 27 patients recordings was rather small; therefore, further research is 
required to even better elaborate how lumbar CSFP wave amplitudes recorded during 
lumbar infusion can be used to predict the ICP wave amplitudes.
The data from Paper V showed that the lumbar infusion-derived parameters Rout and Qpulse 
(wave amplitude)  related weakly, that shunt response after 12 months was not related to 
Rout, but was highly related to the Qpulse and that false negative results of lumbar infusion 
testing were observed in 16% of the patients. Paper VI showed that shunt response can be 
anticipated in 9/10 patients with elevated overnight ICP wave amplitudes, while in only 
1/10 with low ICP wave amplitudes, and that an elevated CSFP wave amplitude during 
lumbar infusion can be used as a screening procedure for selection of iNPH patients for 
shunting. However, even though measurement of lumbar CSFP wave amplitudes improves 
the accuracy of prediction of shunt response as compared to Rout, the problem of false 
negatives from lumbar infusion tests still seems to remain to some extent even with this 
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method. Larger studies addressing these problems are needed, and will hopefully be able to 
clarify whether lumbar infusion testing with measurement of CSFP wave amplitudes has a 
role in assessment of iNPH, or whether these patients should be admitted directly to 
intracranial measurements. Altogether, the existing data point to a potential useful role of 
lumbar infusion testing in assessing patients with iNPH in neurological practice. 
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Cerebrospinal fluid pulse pressure amplitude
during lumbar infusion in idiopathic normal
pressure hydrocephalus can predict response to
shunting
Per K Eide1*, Are Brean2
Abstract
Background: We have previously seen that idiopathic normal pressure hydrocephalus (iNPH) patients having
elevated intracranial pressure (ICP) pulse amplitude consistently respond to shunt surgery. In this study we
explored how the cerebrospinal fluid pressure (CSFP) pulse amplitude determined during lumbar infusion testing,
correlates with ICP pulse amplitude determined during over-night ICP monitoring and with response to shunt
surgery. Our goal was to establish a more reliable screening procedure for selecting iNPH patients for shunt
surgery using lumbar intrathecal infusion.
Methods: The study population consisted of all iNPH patients undergoing both diagnostic lumbar infusion testing
and continuous over-night ICP monitoring during the period 2002-2007. The severity of iNPH was assessed using
our NPH grading scale before surgery and 12 months after shunting. The CSFP pulse was characterized from the
amplitude of single pressure waves.
Results: Totally 62 iNPH patients were included, 45 of them underwent shunt surgery, in whom 78% were shunt
responders. Among the 45 shunted patients, resistance to CSF outflow (Rout) was elevated (≥ 12 mmHg/ml/min) in
44. The ICP pulse amplitude recorded over-night was elevated (i.e. mean ICP wave amplitude ≥ 4 mmHg) in 68%
of patients; 92% of these were shunt responders. In those with elevated overnight ICP pulse amplitude, we found
also elevated CSFP pulse amplitude recorded during lumbar infusion testing, both during the opening phase
following lumbar puncture and during a standardized period of lumbar infusion (15 ml Ringer over 10 min). The
clinical response to shunting after 1 year strongly associated with the over-night ICP pulse amplitude, and also
with the pulsatile CSFP during the period of lumbar infusion. Elevated CSFP pulse amplitude during lumbar
infusion thus predicted shunt response with sensitivity of 88 and specificity of 60 (positive and negative predictive
values of 89 and 60, respectively).
Conclusions: In iNPH patients, shunt response can be anticipated in 9/10 patients with elevated overnight ICP
pulse amplitude, while in only 1/10 with low ICP pulse amplitude. Additionally, the CSFP pulse amplitude during
lumbar infusion testing was elevated in patients with elevated over-night ICP pulse amplitude. In particular,
measurement of CSFP pulse amplitude during a standardized infusion of 15 ml Ringer over 10 min was useful in
predicting response to shunt surgery and can be used as a screening procedure for selection of iNPH patients for
shunting.
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Background
The clinical condition normal pressure hydrocephalus
(NPH) incorporates gait disturbance, mental deteriora-
tion and urinary incontinence, combined with enlarged
cerebral ventricles and a normal lumbar cerebrospinal
fluid pressure (CSFP) [1]. Usually no cause is identified,
in which case the condition is denoted idiopathic NPH
(iNPH). Although the pathophysiology of iNPH is dis-
puted [2], previous studies have shown that shunt sur-
gery can be effective, and that clinical improvement can
be sustained for years [3-5].
Hydrodynamic tests, in particular the lumbar infu-
sion test, have been used for selecting patients for sur-
gery, although the literature is very divergent
concerning its role in iNPH [6]. During lumbar infu-
sion testing, the static CSFP can either be monitored
during constant flow infusion, constant pressure infu-
sion or during bolus infusion to the thecal sac. In our
practice, we have for many years used a modification
of the constant rate infusion test originally described
by Katzman [7] for determination of resistance to CSF
outflow (Rout). However, the utility of Rout in selecting
iNPH patients for surgery is controversial [8-13]. On
the other hand, we have found that the ICP pulse (that
is the amplitude of the single cardiac-beat induced ICP
waves) during over-night ICP monitoring is very useful
for predicting shunt response in iNPH [14]. Thus, in
our previous series of 130 shunted iNPH patients,
shunt response was seen in 9 of 10 patients with ele-
vated ICP wave amplitudes but only in 1 of 10 with
low ICP wave amplitudes [15].
With regard to lumbar infusion testing, the various
approaches (e.g. constant flow, constant pressure or
bolus infusion methods) consistently assess the static
and not the pulsatile CSFP. Others [16] and our group
[8,11,17] have reported experiences from assessing the
pulsatile CSFP during lumbar infusion testing. Based on
these experiences, it could be anticipated that determin-
ing the CSFP pulse during lumbar infusion testing
might better characterize the pressure-volume reserve
capacity than the static CSFP. Moreover, successful
assessment of the pulsatile CSFP during lumbar punc-
ture might represent an advantage, given that lumbar
puncture is a low-risk procedure, and more useful in a
clinical neurological setting than continuous ICP moni-
toring. The pulsatile CSFP can be measured during the
opening phase of lumbar puncture, as well as during
lumbar infusion. Thus, our goal with the present study
was to establish a more reliable screening procedure for
selection of iNPH patients for shunt surgery, based on
determining the CSFP pulse amplitude during lumbar
infusion testing. For this purpose, in the present study
we explored how measurement of the pulsatile CSFP
during lumbar infusion testing correlated with the ICP
pulse monitored over-night and with the response to
shunting. To do this we retrieved all lumbar infusion
tests done during diagnostic work-up for iNPH in this
department during the time period 2002-2007. These
infusion tests were stored as continuous CSFP raw data
(originally sampled at 100-200 Hz). In the present study,
these raw data files were re-analyzed; the CSFP pulse
amplitude was determined during the opening phase
after lumbar puncture and also during a period of lum-
bar infusion (standardized as 15 ml infusion over 10
min). All patients had their ICP monitored over-night;
therefore the infusion test results could be related to the
pulsatile ICP recorded over-night, and with the clinical
response to shunting.
Methods
Patient material
The patient material consisted of all patients being
assessed for iNPH at the Department of Neurosurgery,
Rikshospitalet University Hospital, during the 6-years
period 2002-2007, in whom both over-night ICP moni-
toring and lumbar infusion testing had been done dur-
ing the diagnostic pre-operative work-up. The patients
were referred from local neurological departments based
on their symptoms of gait disturbance, incontinence,
and dementia, combined with radiological
ventriculomegaly.
For diagnostic work-up the patients were hospitalized
for 3 days. Following clinical and radiological assessment
on day 1 (day of admittance), ICP monitoring was done
from day 2 to day 3. The lumbar infusion test was done
on day 3. After discharge from the department on day
3, they returned 1-3 weeks later for surgical treatment
provided this was advocated.
This study was approved by the hospital authority of
Rikshospitalet University Hospital and by the Norwegian
Social Science Data Services. The Regional Committee
for Research Ethics was informed in writing, and had no
objections to the study.
Clinical and radiological assessment
Our diagnostic work-up for iNPH patients has pre-
viously been described [14,15]. In short, based on find-
ings at neurological examination, the severity of clinical
iNPH was graded using our NPH grading scale (scores
ranging from 3-15), which assesses the combined sever-
ity of gait disturbance, urinary incontinence and demen-
tia. The size of the ventricles was assessed using the
linear measure Evan’s index [14].
Diagnostic ICP monitoring and lumbar infusion testing
Diagnostic continuous ICP monitoring was done
through a frontal burr hole prepared under local
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anesthesia. A Codman ICP MicroSensor (Codman,
Johnson & Johnson, Raynham, MA, USA) was placed 1-
2 cm into the brain parenchyma. The ICP monitoring
was done from the evening of day 2 until the morning
of day 3. For each patient we used the over-night ICP
recording from 11 p.m. to 7 a.m., when the patient was
supine in bed.
On the morning day 3, the lumbar infusion test was
done, as previously described [11]. Our strategy repre-
sents a modification of the original Katzman procedure
[7]. The test was performed with the patient in the
supine position by making a midline lumbar puncture
with a 19-gauge needle between the L3 and L4 vertebrae
(one puncture only). The lumbar cerebrospinal fluid
(CSF) pressure was measured continuously using the
Truwave PX-600F Pressure Monitoring Set (Edwards
Life sciences LLC, Irvine, CA, USA), during the opening
phase after lumbar puncture (Po), and during infusion
with a Ringer solution at a standard infusion rate of 1.5
ml/min (fig 1a). The resistance to CSF outflow (Rout)
was calculated as the difference between the plateau
pressure (Pp) and the opening pressure (Po), divided by
infusion rate [11,18].
Surgical treatment
The criteria for surgical treatment during this time per-
iod were based on a combination of clinical and radiolo-
gical observations, and ICP monitoring, as previously
described [15]. The infusion test was considered abnor-
mal when resistance to CSF outflow (Rout) was ≥ 12
mmHg/ml/min. Surgical treatment was implantation of
a ventriculo-peritoneal (VP) shunt: 46 patients received
a HAKIM™ Programmable Valve Shunt System (Cod-
man & Shurtleff, Inc. Medos S.A. CH 2400 Le Locle,
Switzerland), and two patients received a programmable
gravitational shunt (proGAV-Shunt system, Aesculap
Miethke, Tutlingen, Germany.
Follow-up and outcome assessment
Follow-up was done in our out-patient clinic at regular
time intervals, first at three months. As during the pre-
operative examination, the NPH score expressed the
combined severity of gait disturbance, urinary inconti-
nence and dementia. If a patient at some time was
unable to attend the clinic, he or she was interviewed by
phone. The response to shunt surgery was determined
after 12 months. We define an increase ≥ 2 scores on
our NPH scale as representative of clinical improve-
ment, a change which is generally appreciated by the
patients and their families/proxies. Thus, the surgically
treated patients were categorized either as Responders
(change in NPH score ≥ 2) or Non-responders (change
in NPH score < 2), respectively.
Analysis of pulsatile ICP and pulsatile lumbar CSF
pressure
The continuous ICP/CSFP waveforms were stored on a
hospital server (sampling rate 100-200 Hz). A method
[14] implemented in software (Sensometrics software,
dPCom As, Oslo) was used for retrospective analysis of
the CSFP and ICP waveforms. In short, the automatic
algorithm identifies the cardiac-beat induced single pres-
sure waves within the continuous pressure signal. For
each single pressure wave, pulsatility is characterized by
the amplitude [pressure difference (dP) from systolic
maximum to diastolic minimum; fig 1b]. For each con-
secutive six-second (6 s) time window (fig 1b, c), the
method computes mean wave amplitude (representing
the pulsatile pressure), and mean pressure (representing
the static pressure). The 6 s parameter values can be
plotted against time (fig 1a, d), and average values deter-
mined for selected time periods.
The pulsatile ICP was characterized as the average
value of ICP wave amplitude over-night from 11 p.m. to
7 a.m. The pulsatile CSFP was determined both as the
average of CSFP wave amplitude during the opening
phase after lumbar puncture (fig 1d), and also as the
average of CSFP wave amplitude during the standar-
dized infusion time of 10 min, i.e. infusion of 15 ml dur-
ing 10 min at a rate of 1.5 ml/min (fig 1d). We selected
a standardized infusion period of 10 min (corresponding
to a standardized infusion volume of 15 ml) to be able
to compare all the infusion tests.
Statistics
Statistical analyses were performed in SPSS, version 12.0
(SPSS Inc., Chicago, IL, USA). Differences between
groups were determined by one-way ANOVA. Correla-
tions were calculated using bivariate analysis, with deter-
mination of Spearman correlations. Significance was
accepted at the 0.05 level.
Results
Patients
During the period 2002-2007, a total of 214 iNPH
patients underwent diagnostic ICP monitoring as part of
pre-operative work-up in the Department of neurosur-
gery. A subgroup of 62 iNPH patients also underwent
lumbar infusion testing the day following over-night ICP
monitoring (Table 1). Median age of the total material
was 72 years; their symptoms had lasted median 2.8
years (Table 1).
Results of diagnostic ICP monitoring and lumbar infusion
testing
Diagnostic ICP monitoring caused minor complications
in 4 of 62 patients (6.5%), which only included subcuta-
neous wound infections that were treated with
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Figure 1 Analysis of lumbar infusion tests: (a) a plot showing our conventional method of performing a lumbar infusion test, using
constant-rate infusion at 1.5 ml/min of Ringer solution. The plot of mean CSFP against time incorporates the period before infusion
(opening pressure; Po), and during the infusion period (infusion rate of 1.5 ml/min). The plateau pressure (Pp) is indicated. The resistance to CSF
outflow (Rout) is calculated as (Pp - Po)/infusion rate. Two 6 s time windows of the continuous CSFP signal from (b) the start and (c) the
termination of the infusion test are indicated, illustrating the single CSFP pulse waves. (d) Plot of mean CSFP pulse amplitude against time,
indicating the period after lumbar puncture and before infusion (opening phase), and the 10 min period during the infusion. For comparison
between patients we compared the CSFP pulse amplitude during the first 10 min of infusion.
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antibiotics without sequels. The lumbar infusion tests
caused no complications.
The static ICP was normal in all patients (mean ICP
7.6 ± 4.8 mmHg). During over-night ICP monitoring
(11 p.m. to 7 a.m.) the pulsatile ICP was elevated (i.e.
mean ICP wave amplitude ≥ 4 mmHg) in 42 of 62
patients (68%; Table 2). The pulsatile CSFP was elevated
in the sub-group with over-night pulsatile ICP (fig 2);
this was seen during the opening phase after lumbar
puncture (fig 2a), but was even more evident during the
period of lumbar infusion (fig 2b). Thus, among 42
patients with elevated pulsatile ICP over-night (ICP
wave amplitude ≥ 4 mmHg), the pulsatile CSFP was low
(CSFP wave amplitude < 2 mmHg) in 17 subjects during
the opening phase of lumbar puncture (fig 2a), while
pulsatile CSFP was low (CSFP wave amplitude < 4
mmHg) in only 5 subjects during lumbar infusion (fig
2b). The numbers are further detailed in Table 2.
Clinical response to shunting related to the diagnostic
ICP and infusion testing
Forty-five of the 62 patients were shunted, in whom 35
(78%) were shunt responders (Table 1). Major complica-
tions to shunt surgery were seen in 18% of patients
(chronic subdural haematoma in 7%, shunt infection in
2%, visual failure in 2%, and shunt failure in 7%). Minor
complications (headache, abdominal pain, dizziness)
were seen in 13%.
Among the 45 patients being shunted, Rout ≥ 12
mmHg/ml/min was seen in 44 patients. Moreover, of
these 44 patients, 35 (79.5%) were shunt responders,
whereas nine (20.5%) were non-responders. There was a
weak, though significant, correlation between Rout and
change in NPH score (i.e. clinical improvement) 12
months after shunting (Spearman correlation 0.31; P =
0.04; one way ANOVA; data not shown).
When correlating the clinical improvement 12 months
after shunting (change in NPH score) with the CSFP
pulse, we found a highly significant correlation with the
ICP pulse amplitude recorded over-night (Spearman
correlation 0.58; P < 0.001; fig 3a). The clinical improve-
ment after 12 months was not significantly correlated
with the CSFP pulse measured during the opening
phase after lumbar puncture (Spearman correlation, fig
3b). On the other hand, we found a significant correla-
tion between the change in NPH score after 12 months
and the CSFP pulse measured during lumbar infusion
(15 ml over 10 min) (Spearman correlation 0.47; P =
0.002; fig 3c). These observations are further illustrated
in fig 4. The shunt responders and non-responders were
best differentiated by the over-night ICP monitoring (fig
4a), but were also differentiated by the CSFP pulse dur-
ing the opening phase after lumbar puncture (fig 4b)
and more so by the pulse during infusion (fig 4c).
The prediction of shunt response from results of ICP
monitoring or lumbar infusion testing is presented in
Table 3. The data show high positive predictive values
(PPV) and negative predictive values (NPV) for ICP
pulse amplitude recorded over-night, and also for the
CSFP pulse during lumbar infusion.
Discussion
The main observation of this study is that the CSFP
pulse amplitude determined during lumbar infusion
testing showed good correlation with the ICP pulse
amplitude recorded over-night, and also with the clinical
response to shunting in iNPH. The data support our
hypothesis that determining pulsatile CSFP during
Table 1 Demographic data of the patient material
All
patients
Shunt Group
Non-
Responders
Responders
Number 62 10 35
Age (yrs) 72 (37 -
85)
68 (47 - 81) 72 (47 - 81)
Sex (F/M) 31/31 5/5 18/17
Clinical state
Duration of symptoms
(yrs)
2.8 (0.3 -
10)
3 (1 - 10) 3 (1 - 8)
NPH score (15-3) 9 (4 - 14) 11 (6 - 14) 9 (4 - 13)
Radiology
Evan’s index 0.4 (0.3 -
0.5)
0.4 (0.3 - 0.5) 0.4 (0.3 -
0.5)
Table 2 The CSFP pulse during lumbar puncture versus ICP pulse during over-night ICP monitoring
Over-night ICP monitoring* Lumbar puncture
ICP wave amplitude CSFP wave amplitude during opening phase CSF wave amplitude during lumbar infusion
< 2 mmHg ≥ 2 mmHg < 4 mmHg ≥ 4 mmHg
< 4 mmHg (n = 20) 17 3 12 8
≥ 4 mmHg (n = 42) 17 25 5 37
Statistics Sensitivity = 60; Specificity = 85
PPV = 89; NPV = 50
Sensitivity = 88; Specificity = 60
PPV = 82; NPV = 71
*Mean ICP wave amplitude from the period 11 p.m. to 7 a.m.
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Figure 2 Scatter plots of CSFP wave amplitude during the opening period and during lumbar infusion for the two categories of over-
night pulsatile ICP (mean ICP wave amplitude either < 4 mmHg or ≥ 4 mmHg during the period 11 p.m. to 7 a.m.) a) Shows the
pulsatile CSFP (mean CSFP wave amplitude) during the opening phase after lumbar puncture, and (b) during the phase of lumbar
infusion (15 ml over 10 min; 1.5 ml/min). Dotted lines denote different targets for CSFP wave amplitude during the opening period and
during lumbar infusion. Significant differences between groups were tested with one-way ANOVA.
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Figure 3 Graphs showing the correlation between changes in
NPH Score one year after shunt surgery and (a) ICP wave
amplitude during over-night ICP monitoring, (b) CSFP wave
amplitude during the opening phase after lumbar puncture,
and (c) CSFP wave amplitude during the phase of lumbar
infusion (15 ml over 10 min; 1.5 ml/min).
Figure 4 Scatter plots of mean CSFP wave amplitude for shunt
response categories non-responder and responder during (a)
over-night ICP monitoring, (b) during the opening phase after
lumbar puncture, and (c) during the phase of lumbar infusion.
Dotted lines denote cut off targets for the pulsatile pressure (wave
amplitude). The pulse amplitude during the opening phase of
lumbar puncture was not as good a predictor for shunt response as
the amplitude during overnight monitoring and during lumbar
infusion. Significant differences between responders and non-
responders are shown (one-way ANOVA).
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lumbar infusion can be useful as a screening procedure
for selection of iNPH patients for shunting.
Patients
We have previously reported our entire experience of
managing iNPH patients using diagnostic ICP monitor-
ing in the pre-operative work-up during the period
2002-2007 [15]. The present subgroup of 62 iNPH
patients managed during the same time period repre-
sented the patients that also underwent lumbar infusion
testing on day 3. The reason for doing lumbar infusion
testing in these patients was that lumbar infusion testing
has been done since the 1980’s in this department, and
thus represented the traditional management. Therefore,
we considered how this subgroup compared with our
entire cohort of iNPH patients. The present group of 62
patients compared well with our entire cohort during
this time period regarding age, sex, symptom duration,
severity of symptoms and ventricular size (Table 1) [15].
Moreover, in our entire cohort of 130 shunted iNPH
patients, 79% were shunt responders [15], as compared
to 78% of 45 shunted iNPH patients in the present
study. The present material is therefore representative of
our entire experience of managing iNPH. In compari-
son, McGirth et al. [4], using 3-days external lumbar
drainage (ELD) and positive finding of A- or B-waves on
spinal puncture, found in 132 patients a long term shunt
response rate of 75%. Moreover, using gait improvement
after 3-days ELD to aid selection for surgery, Marmarou
et al. [3] reported clinical improvement in 76 (91%) of
84 patients.
Overnight pulsatile ICP versus pulsatile CSFP during
lumbar infusion testing
Based on our experience of diagnostic ICP monitoring
in 214 iNPH patients [15], we categorized pulsatile ICP
as being elevated when ICP wave amplitude is ≥ 4
mmHg during over-night monitoring. Thus, among 130
shunted iNPH patients, 93% with elevated ICP pulse (i.e.
ICP wave amplitude ≥ 4 mmHg during over-night moni-
toring) were shunt responders whereas only 10% with
low ICP pulse (i.e. ICP wave amplitude < 4 mmHg over-
night) responded to shunting [15]. In the present group,
68% of patients had elevated ICP pulse.
The present dataset clearly showed that pulsatile CSFP
was elevated in those with elevated over-night ICP
pulse. This was most evident during the period of lum-
bar infusion, as compared to the opening phase after
lumbar puncture (fig 2; Table 2). Examining simulta-
neous measurements of lumbar CSFP pulse and intra-
cranial ICP pulse during lumbar infusion testing, we
have previously shown in 35,532 CSFP/ICP single wave
pairs that the lumbar CSFP wave amplitudes are about 2
mmHg below the simultaneous cranial ICP wave ampli-
tudes [17]. Thus, from this experience, we categorized
ICP wave amplitudes ≥ 4 mmHg as indicative of ele-
vated pulsatile ICP [15], and lumbar CSFP wave ampli-
tude ≥ 2 mmHg as indicative of elevated pulsatile CSFP
[8,17].
One explanation for this discrepancy between the
intracranial and intraspinal compartments is the differ-
ence in compliance (i.e. pressure-volume reserve capa-
city) between the compartments. This assumption is
further illustrated in fig 5; the pressure-volume curve of
the intraspinal compartment is moved to the right as
compared to the curve of the intracranial compartment,
indicative of higher compliance in the intraspinal than
the intracranial compartment. A methodological draw-
back relates to the fact that the pulsatile CSFP during
lumbar infusion testing was measured through the same
needle as the infusion. Therefore the pulsatile CSFP
during infusion might be slightly increased due to the
resistance of the lumbar needle at the infusion rate of
1.5 ml/min. Measurements from a second needle might
prevent this effect, and give slightly lower pulsatile CSFP
values. However, the impact of this effect is probably
minor. Thus, simultaneous measurements of pulsatile
ICP and lumbar pulsatile CSFP during lumbar infusion
showed that the lumbar CSFP pulse amplitudes were
about 2 mmHg below the ICP pulse amplitudes both
before and during the infusion [17].
In the present study, we solely focused on the pulsatile
pressures. In line with our previous experience [15],
over-night static ICP was normal in these patients
Table 3 Number of shunt responders/non-responders depending on results of lumbar puncture or ICP monitoring
Lumbar puncture ICP monitoring*
CSFP wave amplitude
during opening phase
CSF wave amplitude
during lumbar infusion
ICP wave amplitude
< 2 mmHg ≥ 2 mmHg < 4 mmHg ≥ 4 mmHg < 4 mmHg ≥ 4 mmHg
Responder (n = 35) 13 22 4 31 1 34
Non-Responder (n = 10) 8 2 6 4 7 3
Statistics Sensitivity = 63; Specificity = 80
PPV = 92; NPV = 38
Sensitivity = 88; Specificity = 60
PPV = 89; NPV = 60
Sensitivity = 97; Specificity = 70
PPV = 92; NPV = 88
* Mean ICP wave amplitude from the period 11 p.m. to 7 a.m. PPV = Positive predictive value; NPV = Negative predictive value.
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(hence the term normal pressure hydrocephalus). Others
have previously examined differences in the static pres-
sures between intraspinal and intracranial compart-
ments. Several authors have found that the short-lasting
opening CSFP measured during the opening phase of
lumbar puncture (opening pressure) did not relate well
to ICP recorded over-night [17,19,20]. Others found
lumbar mean CSFP to agree with the ICP across a large
pressure interval [21]. The reason for the discrepancy is
that the static pressure depends on the baseline level
and zero calibration since the static pressure refers to
the difference between the atmospheric pressure and the
intra-compartment pressure [22,23]. The pulsatile pres-
sure, characterized by the wave amplitude, on the other
hand, refers to the intra-signal difference between the
diastolic and systolic pressures (fig 1), thus being inde-
pendent of the baseline pressure level [22,23]. We have
previously shown that the two sensors used for pressure
monitoring in this study are equivalent for pulse pres-
sure wave analysis; comparing a total of 218,589 single
pressure wave pairs from the intracranial compartment
from these two pressure sensors revealed a difference in
pulse pressure amplitude of only 0.13 mmHg (95% con-
fidence interval 0.12 -0.13 mmHg) [23].
Clinical response to shunting related to the diagnostic
ICP and infusion testing
Among those 37 patients with elevated ICP pulse over-
night (i.e. mean ICP wave amplitude ≥ 4 mmHg; time
period 11 p.m. - 7 a.m.), 34 (92%) were shunt
responders, while among those eight with low ICP pulse
overnight (i.e. mean ICP wave amplitude > 4 mmHg;
time period 11 p.m. - 7 a.m.) only one (13%) responded
to shunting (Table 3). These numbers compare with our
entire series of shunted iNPH patients during this same
time period (2002-2007) [15].
During lumbar infusion testing, our standard approach
has been to determine resistance to CSF outflow (Rout).
The cut-off value for considering Rout pathologically ele-
vated varies in the literature. According to our routine,
we have considered Rout ≥ 12 mmHg/ml/min as abnor-
mal [6,12]. Therefore, among our 45 shunted iNPH
patients, Rout ≥ 12 mmHg/ml/min was seen in all but
one patient. Among the resulting 44 patients, 35 (80%)
were shunt responders. In general, the role of Rout in
predicting shunt response is still highly disputed
[6,8-10,13]. Based on our earlier experience with deter-
mination of Rout [8,11], we have now discontinued using
the Rout for the purpose of selecting iNPH patients for
shunting.
In this cohort, we found a highly significant correla-
tion between overnight pulsatile ICP and the degree of
clinical improvement seen 12 months after shunting (fig
3a). The correlation between Rout and clinical improve-
ment was weaker, though it reached significance. These
observations compare with our previous experience
[8,11,15]. A new observation here was that the CSFP
pulse amplitude measured during lumbar infusion (15
ml over 10 min) correlated better with clinical improve-
ment after shunting (fig 3c). This latter observation
Figure 5 Assessments of intracranial compliance and lumbar compliance during lumbar infusion. This diagram illustrates the intracranial
and lumbar pressure-volume curves and the relationship to the pulsatility parameters. Under normal physiologic conditions with high
intracranial compliance, ICP wave amplitude is correspondingly small. As intracranial compliance decreases (steep part of the pressure-volume
curve), the brain behaves increasingly like a linear elastance and so variations in intracranial volume correlate increasingly well with changes in
ICP wave amplitude, thus the steepness of the pressure-volume curve accounts for large-amplitude ICP waveforms. The cranial pressure-volume
curve is left of the lumbar pressure-volume curve, illustrating that compliance is higher in the lumbar compartment.
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compares with recently reported observations, focusing
on the distribution of the CSFP pulse during lumbar
infusion testing [8]. It should be noted that prior to
shunting the Rout and not the CSFP pulse was used to
select patients for shunt surgery. As shown in Table 3,
clinical response to shunting was best predicted by
over-night ICP monitoring, in line with previous obser-
vations [15]. The most important observation of this
study is that clinical shunt response was also predicted
by the CSFP pulse during lumbar infusion (Table 3).
Thus, when CSFP wave amplitude was ≥ 4 mmHg dur-
ing lumbar infusion of 15 ml over 10 min, clinical
response to shunting was predicted with a sensitivity of
88 and specificity of 60 (PPV 89; NPV 60).
Taken together, the present results suggest that deter-
mining CSFP pulse amplitude during lumbar infusion
testing can be useful as a screening procedure for selec-
tion of patients to shunt surgery. An advantage of lum-
bar infusion testing, as compared to over-night ICP
monitoring, is that the procedure is a low cost and low
threshold approach with few complications that is
widely used. Moreover, determining the CSFP pulse was
more useful than the Rout determination.
Measuring pulsatile CSFP during lumbar infusion versus
intracranial compliance
Figure 5 provides a tentative explanation of what is
being tested while monitoring pulsatile CSFP during
lumbar infusion. We assume that the CSFP pulse pro-
vides an indirect measure of the compliance (pressure-
volume reserve capacity) of the intraspinal compart-
ment. When the compliance is being reduced, the
amplitudes (dP) are increasing [24,25]. The wave ampli-
tude (dP) is the pressure response to the volume change
caused by each cardiac contraction, which in the intra-
cranial compartment is about 1 ml [26]. During lumbar
infusion the compliance is being artificially reduced
(moving to the right on the pressure-volume curve).
When compared to the cranial pressure-volume curve,
the spinal pressure-volume curve is shifted to the right
because compliance in the spinal compartment is higher
than in the intracranial compartment [17]. For this rea-
son it is necessary to infuse fluid intrathecally to reach
the same amplitude values in the lumbar compartment
as in the intracranial compartment. Although the wave
amplitudes do not measure compliance directly, they are
related to compliance [27] and elevated ICP pulse is
associated with reduced intracranial compliance [28].
An important effect of shunting is improved compliance
and this is why elevated ICP pulse measured during
over-night ICP monitoring and also during lumbar infu-
sion, accurately predicts the shunt response in these
patients (Table 3).
Conclusions
Taken together, determining CSFP pulse amplitude dur-
ing lumbar infusion in this cohort of iNPH patients was
useful for predicting shunt response. The data suggest
that the approach can be used for screening of iNPH
patients for shunt surgery.
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